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ABSTRACT OF THE DISSERTATION 
 
IN VIVO CHARACTERIZATION OF EPILEPTIC TISSUE WITH OPTICAL 
SPECTROSCOPY  
by 
 
Nitin Yadav 
 
Florida International University, 2012 
 
Miami, Florida 
 
Professor Wei-Chiang Lin, Major Professor 
For children with intractable seizures, surgical removal of epileptic foci, if identifiable 
and feasible, can be an effective way to reduce or eliminate seizures.  The success of this 
type of surgery strongly hinges upon the ability to identify and demarcate those epileptic 
foci. The ultimate goal of this research project is to develop an effective technology for 
detection of unique in vivo pathophysiological characteristics of epileptic cortex and, 
subsequently, to use this technology to guide epilepsy surgery intraoperatively.  In this 
PhD dissertation the feasibility of using optical spectroscopy to identify unique in vivo 
pathophysiological characteristics of epileptic cortex was evaluated and proven using the 
data collected from children undergoing epilepsy surgery.  
 In this first in vivo human study, static diffuse reflectance and fluorescence 
spectra were measured from the epileptic cortex, defined by intraoperative ECoG, and its 
surrounding tissue from pediatric patients undergoing epilepsy surgery. When feasible, 
biopsy samples were taken from the investigated sites for the subsequent histological 
analysis.  Using the histological data as the gold standard, spectral data was analyzed 
with statistical tools.  The results of the analysis show that static diffuse reflectance 
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spectroscopy and its combination with static fluorescence spectroscopy can be used to 
effectively differentiate between epileptic cortex with histopathological abnormalities and 
normal cortex in vivo with a high degree of accuracy. 
 To maximize the efficiency of optical spectroscopy in detecting and localizing 
epileptic cortex intraoperatively, the static system was upgraded to investigate 
histopathological abnormalities deep within the epileptic cortex, as well as to detect 
unique temporal pathophysiological characteristics of epileptic cortex. Detection of deep 
abnormalities within the epileptic cortex prompted a redesign of the fiberoptic probe.  A 
mechanical probe holder was also designed and constructed to maintain the probe contact 
pressure and contact point during the time dependent measurements. The dynamic diffuse 
reflectance spectroscopy system was used to characterize in vivo pediatric epileptic 
cortex.  The results of the study show that some unique wavelength dependent temporal 
characteristics (e.g., multiple horizontal bands in the correlation coefficient map γ(λref = 
800 nm, λcomp,t)) can be found in the time dependent recordings of diffuse reflectance 
spectra from epileptic cortex defined by ECoG.   
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1. Background         
1.1. Pediatric Epilepsy and Management 
It is estimated by the Epilepsy Foundation that about 45,000 children under the age of 15 may 
develop epilepsy each year [1]. One common symptom of epilepsy is seizures, and repeated 
seizures are damaging to children because they can cause irreversible injuries to the brain as well 
as interfere with the normal brain development [2]. Epilepsy is not a name of a disease; it is 
rather a set of common symptoms that arise from different disorders of the brain.  According to 
the International League Against Epilepsy (ILAE), epilepsy is defined as a chronic condition of 
the brain characterized by an enduring propensity to generate epileptic seizures, and by the 
neurobiological, cognitive, psychological, and social consequences of this condition. Thus, 
epilepsy can be interpreted as a disorder of brain which exists even when there is no seizure.  
Epilepsy is a discontinuous process, and it may spontaneously occur at anytime.   
 Seizures are the most common observable symptom of epilepsy.  Seizures can be 
classified as: 
1. Partial seizures: They are also called focal or localized seizures.  They originate in more 
specific locations of the brain and mostly are developed from external injuries. 
2. Generalized seizures: They typically occur in both sides of the brain and mostly are 
genetic.  
 Partial seizures are more common than generalized seizures. The cause of a seizure is 
determined in about 28% of partial epilepsy patients. In the rest, however, epilepsy is deemed 
idiopathic, which means that the cause is unknown [3]. A seizure's effect depends on the location 
in the brain. A person can seem to be confused after a seizure or can feel a spasm or, in the 
extreme case, may become unconscious. 
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 While not completely proven, studies have identified various potential causes for epilepsy 
including chemical-malfunctioning of ion channels for sodium, potassium and calcium in 
neurons and astrocytes [4-7], abnormalities in neurotransmitters like GABA, serotonin and 
acetylcholine [5,8-10], or genetic or physical causes like fever, vaccinations, head injuries, viral 
infections and brain tumors [11, 12]. 
1.1.1. Pharmaceutical Therapies 
Epilepsy is first treated with antiepileptic medications. Selection of medications is usually 
determined by the types of seizures and epilepsy syndromes, since certain medications are more 
effective against specific seizure types and syndromes than others. Achieving good control of 
seizures with drug treatment generally depends on choosing the right drug, minimizing the 
number of drugs prescribed, and educating the patient and family to encourage daily use as 
prescribed.  Other factors that can affect the choice of drug include potential side effects, the 
dosing regimen -- whether it is simple or difficult to follow -- the age of the patient, childbearing 
potential, use of other medications, lifestyle, and, in some cases, cost.  Whenever possible, using 
one drug is preferred. This drug may be prescribed in increasing doses until seizures are 
controlled or a side effect occurs. If the drug is not effective or if side effects are hard to live 
with, this drug will probably be gradually stopped while another one is slowly introduced. 
 In general, antiepileptic drugs eliminate seizures for about half of all patients with 
epilepsy; for another 20-30%, the intensity and number of seizures is reduced to the point where 
the person can live and work normally. The seizures in the remaining 20% of people with 
epilepsy do not respond well to current medications, and their condition is termed “refractory to 
treatment.” For those patients, other treatment options, such as surgery, vagus nerve stimulation, 
or the ketogenic diet, may be explored. 
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1.1.2. Dietary Therapy 
The diet is based on the observation that starvation, which burns fat for energy and produces 
ketones, has an antiepileptic effect. The goal of the diet is to make the body get its energy from 
fat and become ketotic. It is primarily done by administering a ketogenic diet to the epilepsy 
patients. The ketogenic diet is a high-fat, adequate protein, very low carbohydrate diet that is 
both calorie and fluid restricted and initiated in hospital because of risks of severe metabolic 
abnormalities during and after the initial fasting period to create and maintain ketosis. Generally, 
medications are not discontinued along with ketogenic diet.  How ketogenic diet reduces seizures 
remains somewhat unclear and is probably multifactorial, but many studies have clearly 
demonstrated it effective in >50% reduction of seizures in 38% children [13]. 
 There are also adverse effects associated with ketogenic diet, including sluggishness 
during the initial treatment.  Staying on ketogenic diet for a long period of time could lead to 
kidney stones, high cholesterol, dehydration, constipation, slowed growth or weight gain, and 
bone fractures [14]. It should also be noted that certain particular epilepsy syndromes may 
respond better to ketogenic diet than others [15]. 
1.1.3. Vagus nerve stimulation 
Vagus nerve stimulation (VNS) is a relatively new procedure in pediatric epilepsy management. 
It involves implanting an electronic device in the upper chest that delivers electrical stimulation 
to the vagus nerve in the neck to control seizure frequency, severity, and duration.  VNS is used 
in adjunct treatment with antiepileptic drugs. It has been approved by the US Food and Drug 
Administration for use in treating partial seizures in adults and adolescents over age 12 after 
medical therapy has failed to control the seizures.  
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 The VNS therapy system consists of the implantable pulse generator and bipolar VNS 
therapy lead, a programming wand with software, a tunneling tool, and a handheld magnet.  
Once implanted, the device delivers a regular pattern of stimulation. Patients can turn the device 
on if they feel a seizure coming on by using a special magnet, which in some cases may prevent 
the seizures. Medical studies of the device suggest that some patients will gain some benefit from 
the VNS device although complete seizure control is rare. Approximately one-third of patients 
receiving VNS therapy experience at least a 50% reduction in seizure frequency with no adverse 
cognitive or systemic effects [16]. Moreover, clinical findings indicate that the effectiveness of 
VNS therapy continues to improve over time, independent of changes in AEDs or stimulation 
parameters [16]. Tolerance does not appear to be a factor with VNS therapy, even after extended 
periods of time. Most people continue to take antiepileptic drugs while receiving the VNS 
therapy. The most commonly reported side effects are hoarseness, coughing and breathlessness 
[17].  
1.2. Epilepsy Surgery  
Epilepsy is regarded as refractive if it has been continuously active for 3 years in spite of 
adequate trials of therapy with three or more main-line antiepileptic drugs, and if seizures are 
frequent (more than one per month). The best way to combat refractive epilepsy is to remove the 
epileptic focus and its surroundings. 
1.2.1. One Stage Surgery 
In one stage surgery, electrocorticography (ECoG) is heavily relied on in the operating room just 
before the resection. Here interictal activities of epileptic cortex is captured by ECoG and then 
used to define the area of resection. The epileptic cortex defined by ECoG may have consistent 
focality in interictal spiking, rhythmic features, trains of focal fast beta activity, or focal 
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attenuation of background [18-21]. One stage epilepsy surgery has advantages over the two-stage 
one (see below) in terms of cost and less risk of infection. Awake intraoperative ECoG can also 
be used to map eloquent cortex [22-24].  
1.2.2. Two Stage Surgery 
In a two-stage epilepsy surgery, the initial operation aims to place subdural electrodes for seizure 
monitoring [16-19]. Ictal zone is then demarcated by seizures occurrence. Sometimes functional 
mapping may be performed during the seizure monitoring stage. The information collected 
during the monitoring stage will be used to define the zone of resection for the second operation 
taking place about one week after the first operation [25]. In planning the resection, a clear 
relationship between eloquent cortex and epileptic area needs to be defined [26, 27]. Typically, a 
margin of at least 0.5-1 cm is required to spare function. Language cortex can be mapped in 
children as young as 2.5 years of age [26, 27].  Two-stage epilepsy surgery is used when the 
epileptic zone is discrete, no lesions are present in the imaging study, or the planned resection is 
adjacent to eloquent cortex [28]. The main disadvantages of a two-stage surgery are higher costs 
and risks of infection [29, 30]. 
1.3. Technologies Used in the Planning of Epilepsy Surgery 
Current technologies used in diagnosis of epilepsy and demarcations of epileptic tissue are: 
1.3.1. Electroencephalogram (EEG) 
EEG is used to detect abnormal electrical activities in the brain associated with epileptic 
seizures. In an EEG study, multiple electrodes are placed on scalp, and the brain wave patterns 
are recorded and studied. Through the study, the abnormal patterns that indicate seizures can be 
identified. Ideally, EEG should be performed within 24 hours of a seizure. The duration of EEG 
recordings vary from an hour to a few days in case of intractable epilepsy.  
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 An EEG study performed with simultaneous video recording is called a video EEG study 
[31, 32].  It provides the doctors insights into the seizure type and the possible brain area where 
the epileptic activities originate. Simultaneous video recordings can also provide information to 
the determination of paroxysmal event frequency and aid in the diagnosis of nonepileptic 
seizures, as well as help with seizure and epilepsy classification [33]. 
1.3.2. Computerized Tomography (CT) Scans 
CT scans take x ray images of the brain from many different angles to determine its 
crosssectional configuration with the aid of a computerized reconstruction algorithm. In the 
planning procedure of an epilepsy surgery, CT scans may be performed to detect the structural 
abnormalities in the brain associated with epileptic seizures [34].  An iodine based dye may be 
injected into a patient before taking a CT scan in order to enhance image contrast in certain 
anatomical structures such as blood vessels. The amount of radiation used in a CT scanning 
procedure is quite low, so it is safe to perform CT scans repeatedly.  
1.3.3. Magnetic Resonance Imaging (MRI) 
MRI is an imaging modality that uses a magnetic field to change the spin of the atomic particles 
in the body and hence perform three-dimensional imaging.  The MRI images can be used to 
identify abnormal areas in the brain, small brain tumors, blood vessel abnormalities, and changes 
in white matter. In the planning stage of an epilepsy surgery, MRI is used to detect the structural 
abnormalities in the brain associated with epileptic seizures [35, 36].  MRI is recommended for 
children after their first seizure and seizures that are associated with any unexplained significant 
mental or motor problems. 
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1.3.4. Other Advanced Imaging Techniques 
Another popular imaging technology used in the planning stage of an epilepsy surgery is 
Positron Emission Tomography (PET).  It measures regional metabolic activities in the brain, 
based on which brain functions and/or disorders are detected. During a seizure, the area 
responsible for the seizure will show up as an area of increased glucose use in the PET images 
[37].  Between the seizures, the epileptic focus shows a characteristic pattern of reduced need for 
glucose in the PET images [38]. PET has proven to be an important diagnostic tool in selecting 
patients with partial epilepsy, in particular with foci in the temporal lobe, for resective surgery 
[39].  Single-photon emission computer tomography (SPECT) is another useful technology to 
plan an epilepsy surgery. It identifies patterns of change in cerebral blood flow during seizures in 
children [40]. It could be useful in clarifying the poorly understood interplay of the interictal and 
ictal states in human focal epilepsy [41]. SPECT and PET are generally helpful if MRI is not 
much useful for deciding on surgery [42]. 
 Diffusion Tensor Imaging or DTI is used for tracing subtle changes in directionality and 
magnitude of water diffusion due to diseases. It enables visualization and characterization of 
white matter fascicli in two and three dimensions. It is used to noninvasively assess the 
molecular and biochemical environment of cerebral tissue [40, 43]. Diffusion weighted images 
can provide information on the molecular movements in the microstructure. DTI can aid in 
characterizing and measuring the diffusive transport of water molecules by means of an effective 
diffusion tensor, D. The symmetric tensor measurements contains useful information about the 
tissue microstructure and architecture [44].  
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1.3.5. ECoG 
Electrocorticography (ECoG) was first used in 1940 to exactly find the location and extent of the 
epileptic brain tissue prior to epileptic surgery. It is now considered as a golden standard for 
demarcation of epileptic cortex.  ECoG is an invasive procedure which involves placing the 
electrodes to monitor electrical activity from cerebral cortex on an exposed brain surface. It can 
identify the areas which are epileptic in nature. The recording equipment used for ECoG is same 
as that for scalp EEG; a two-dimensional electrode array provides simultaneous recording from 
multiple locations. The recording electrodes must make a light contact with the exposed cortex to 
generate signals with high signal to noise ratio. Signal filters are set at 0.3–70 Hz and the 
sensitivity at 50–75 μV/mm in an ECoG study, otherwise clipping of spikes (often 1–3 mV) and 
excessive amplification of other activity could impair data analysis and interpretation. ECoG 
provides more valuable information than EEG because it has a high spatial and frequency 
resolution and is immune from the eye and muscle artifacts.  
 Preoperative studies like EEG, CT Scans, and MRI are essential to identify epileptic 
activities within the brain that are accessible to resection. Lateralization and at least a rough 
localization of the epileptic focus is absolutely necessary to allow correct placement of recording 
electrodes. Therefore, the intraoperative ECoG does not replace presurgical evaluation. 
Furthermore, it is impossible to use ECoG to distinguish primary epileptiform discharges from 
secondary propagated discharges arising at a distant epileptic site [45, 46].  
1.4. Optical Technologies for Intraoperative Surgical Guidance  
1.4.1. Biomedical Optics  
Light traveling in a biological tissue is governed by two tissue optical properties, namely 
absorption coefficient µa(λ) [1/cm] and scattering coefficient µs(λ) [1/cm].  In the visible 
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wavelength region (i.e., 400 to 700 nm), the absorption in a biological tissue is caused primarily 
by hemoglobin.  Therefore, the absorption coefficient of a biological tissue in the visible 
wavelength region may be expressed as 
ߤ௔ሺߣሻ ൌ 	2.303 ൈ ሾܪܾሿ 	ൈ ሺܵܣܱܶଶ ൈ ߳ு௕ைଶ ൅ ሺ1 െ ܵܣܱܶଶሻ ൈ ߳ு௕ሻ [1/cm]     (1.1) 
where [Hb] is the hemoglobin concentration in mole, SatO2 is hemoglobin oxygenation, ߳ு௕ைଶ is 
the molar extinction coefficient of oxy-hemoglobin [1/cmM], and ߳ு௕  is the molar extinction 
coefficient of hemoglobin [1/cmM].  Because the molar extinction coefficient of hemoglobin 
varies significantly in accordance with its oxygenation (see Figure 1.1),  it is possible to obtain 
the two critical hemodynamic parameters (i.e., [Hb]  and SatO2) through the study of µa(λ) of the 
biological tissue.   
 Light scattering inside a biological tissue is a result of spatial variation in tissue 
refractive index.  Various intra- and extra-cellular components contribute to the light scattering, 
and their contributions, in general, are size and density dependent [48, 49].  µs(λ) is defined in 
the way that the probability of a scattering event over a short distance s will be µs(λ)×s.  µs(λ) 
may be correlated with the size/density of scatterers in a biological tissue using Mie theory.  That 
is 
ߤ௦′ ሺߣሻ 	ൌ 	 ߤ௦ሺߣሻ ൈ ሺ1 െ ݃ሻ ൌ ܽ ൈ ݉ି௕ [1/cm],                          (1.2) 
where g is unisotropic factor and 310×= λm .  It has been shown that the morphological and 
structural characteristics of a biological tissue may be assessed through its µs(λ) [50]. 
1.4.2.    Optical Spectroscopy  
Optical spectroscopy is a technology developed to study the intrinsic properties of a material 
through its interaction with light.  Over the past two decades, researchers in the field of 
biomedicine have been utilizing optical spectroscopy to perform minimally-invasive, non-
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destructive detections of tissue diseases and injuries in various organs like cervix, brain, skin, 
pancreas, colon, breast and esophagus [51-61]. The types of optical spectroscopy frequently used 
to perform optical diagnosis include diffuse reflectance spectroscopy and fluorescence 
spectroscopy. Diffuse reflectance spectroscopy is used primarily to detect tissue hemodynamics 
as well as the compositional and structural information [62].  It has the advantage of being 
affordable and portable and producing diagnostic results in real time.   
 
Figure 1.1: Molar Extinction Coefficients of oxy-hemoglobin (blue) and deoxy hemoglobin (red) 
as a function of wavelength [47]. 
  
 Fluorescence spectroscopy is used to detect and quantify molecules that can absorb a 
high energy photon and yield a low energy fluorescence photon (i.e., fluorophores).  In 
biological tissues, the endogenous molecules possessing such a capability include: NADH, 
FAD2+, Tryptophan and its derivatives (e.g. serotonin, and dopamine) and collagen [63].  In the 
research field of optical diagnosis, fluorescence spectroscopy is often used to gauge the redox 
state of NADH and hence the metabolic activities of in vivo organs [64].  Accurate 
interpretations of fluorescence spectra from in vivo tissue can be very challenging because the 
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propagation of both excitation and emission (fluorescence) photons is strongly influenced by the 
optical properties of tissue [65].     
 
1.4.3.   Intraoperative Demarcation of Neoplastic and Epileptic Lesions Using Optical 
Spectroscopy   
The feasibility of using optical spectroscopy to intraoperatively guide cancer surgery has been 
evaluated in various cancer types [54, 66, 67].  Several studies have shown that combined 
fluorescence and diffuse reflectance spectroscopy can accurately detect brain tumor in vivo and 
hence may be used to guide brain tumor resection [51, 68].  A recent study also demonstrates the 
potential of using diffuse reflectance spectroscopy alone to detect pediatric brain tumors in vivo 
[69].  The concept of using optical spectroscopy to aid epilepsy surgery is very new, and it has 
only been explored in a few studies to date [70, 71]. However, a diffuse reflectance imaging 
modality (i.e., intrinsic optical imaging) has been used to study the hemodynamic characteristics 
of human epileptic cortex in vivo [72, 73].  It should be noted that the intrinsic optical imaging 
modality only acquires the diffusely reflected light from the cortex at a few selected 
wavelengths.  The accuracy of using optical modalities, including fluorescence and diffuse 
reflectance spectroscopy, to demarcate epileptic cortex intraoperatively, nevertheless, has not 
been proved yet.    
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2. Statement of Purpose 
2.1. Hypothesis 
As discussed in the background section, epilepsy leads to drastic changes in the hemodynamic, 
metabolic, and compositional characteristics of the brain tissue, which are tapped by existing 
techniques like MRI for seizure localization.  Because of the unique advantages provided by 
optical spectroscopy, it can potentially play a significant role in the future management of 
pediatric patients who have intractable epilepsy and are good candidates for epilepsy surgery. 
More specifically, optical spectroscopy may be used to detect unique pathophysiological 
characteristics of epileptic cortex in a nondestructive manner in vivo, which, in turn, can assist 
surgeons to accurately differentiate an epileptic cortex from a nonepileptic brain during an 
epilepsy surgery.  The primary objective of this dissertation is to prove this concept, and its 
central hypothesis is: fluorescence and diffuse reflectance spectroscopy can detect interictal 
pathophysiological characteristics associated with pediatric epileptic cortex in an intraoperative 
fashion.  To validate this hypothesis, the following specific aims were proposed and carried out. 
2.2. Specific Aims 
Aim 1: To identify static fluorescence and diffuse reflectance spectral features that differentiate 
between normal and epileptic pediatric cortex defined by pathology.  The study outcomes related 
to this specific aim are presented in chapter 3 of this dissertation. 
Aim 2: Develop a portable fiberoptic spectroscopic system with capability to capture dynamic 
diffuse reflectance spectra from in vivo brain in an intraoperative environment.  The study 
outcomes of this specific aim are reported in chapters 4 and 5 of this dissertation.     
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Aim 3: Identify dynamic diffuse reflectance spectral features associated with pediatric epileptic 
cortex defined by ECoG and pathology.  The study outcomes related to this specific aim are 
presented in chapter 6 of this dissertation. 
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3. In Vivo Characterization of Epileptic Cortex using Static Fluorescence and Diffuse 
Reflectance Spectroscopy 
3.1. Introduction 
According to the Epilepsy Foundation, of the 200,000 new cases of epilepsy diagnosed each year 
in the United States, 45,000 are children under the age of 15 [1]. Epilepsy is considered a severe 
neurological disorder in children, because its primary symptom, seizure, can severely damage 
normal brain development. When the pharmaceutical and/or dietary therapies fail to achieve 
seizure freedom, epilepsy is defined as refractory [78, 79]. For pediatric patients with refractive 
epilepsy, surgical intervention, when applicable, becomes necessary. Since the success of 
epilepsy surgery is determined by the amount of seizure-inducing cortex (i.e., epileptic cortex) 
removed, there arises a need to develop some systematic methodology that accurately detect and 
demarcates the epileptic cortex pre- and intra-operatively.    
 Non-invasive diagnostic technologies commonly used in the pre-surgical planning of 
epilepsy surgery include electroencephalography (EEG), Video EEG, and several noninvasive 
imaging modalities like computed tomography (CT), single-photon emission computed 
tomography (SPECT), magnetic resonance imaging (MRI), positron emission tomography 
(PET), and diffusion tensor imaging (DTI) [80-84]. Advancements in noninvasive imaging 
modalities over the past two decades have greatly improved their ability to identify epileptic 
cortex or lesions and, hence, surgical outcomes [80, 83, 84]. However, the above mentioned 
diagnostic technologies, when used individually, cannot provide definitive information upon 
which surgery can be based; they, at best, provide approximate locations of seizure origins due to 
their limited sensitivity and spatial resolution [80, 83, 45]. In addition, these technologies may be 
difficult to use on pediatric patients who may not be able to remain motionless for extended 
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periods of time [85]. Finally, spatial coordinates of the epileptic cortex defined in these studies 
may lose their value because of brain shift/deformation during the craniotomy procedure [86-89].  
 When EEG/imaging studies are inconclusive, electrocorticography (ECoG) may be used 
to perform invasive mapping of the ictal onset zone [45, 90]. In addition, ECoG is used in the 
operating room to directly detect interictal epileptiform discharges from the abnormal brain 
region, which are used to define the resection margins for the surgeon. However, ECoG may 
detect interictal discharges in normal brain as well, as a result of electrical spreading, and 
epileptic focus localization using interictal discharges is subject to a certain amount of 
uncertainty in anesthetized brain [90]. Histological evaluation of epileptic cortex has uncovered 
many unique pathological features such as balloon cells and cortical dislamination [91]. This 
information usually is acquired through post-operational histopathological analysis of the 
resected brain specimens and is not immediately available in the operating room. While 
histopathological features of the lesion may not correlate with surgical outcomes [83, 19], it is 
not yet clear if their presence can be used as an objective indicator with which to demarcate the 
area of epileptic brain. The technological shortcomings and limitations described above 
frequently lead to incomplete removal of epileptic lesions, which adversely affects surgical 
outcomes. This is especially true for cases of extra-temporal epilepsy, which is common in 
children [80, 84, 85, 19]. For these reasons, new technologies for intraoperative identification 
and demarcation of the epileptic brain area are needed to enhance the prognosis of epilepsy 
surgery for patients with intractable non-lesional extra-temporal epilepsy. These new 
technologies, ideally, should be developed in accordance with the intrinsic characteristics of 
epileptic brain during the interictal period.  
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 Because the intrinsic compositional and structural characteristics of tissue strongly affect 
its absorption and scattering properties, it is feasible to use the interaction between light and 
biological tissue to estimate these qualities and, hence, detect whatever alterations that result 
from disease development [51, 56, 74, 92-99]. Such an optic-based diagnostic technology often 
is termed optical diagnosis; its advantages include its low cost, portability, and real-time 
application. Among the existing optical diagnostic methodologies, many are based on 
fluorescence and diffuse reflectance spectroscopy. This is because several intrinsic biological 
chromophores (e.g., hemoglobin) and fluorophores (NADH) can be used to assess critical 
intrinsic physiological characteristics of biological tissue, including its hemodynamics and 
metabolism [98, 99 64, 100, 101].  The feasibility of using optical spectroscopy to intra-
operatively guide cancer surgery has been evaluated for various cancer types. Several studies 
have shown that combined fluorescence and/or diffuse reflectance spectroscopy can accurately 
detect brain tumors in vivo and, hence, may be used to guide brain tumor resection [51, 69]. 
However, applying optical spectroscopy to the detection of epileptic cortex has only been 
explored in a limited fashion to date [70-72, 101, 102]. 
 In this chapter, combined fluorescence and diffuse reflectance spectroscopy was used to 
detect unique pathophysiological and morphological characteristics of epileptic cortex in an in 
vivo human study. Static diffuse reflectance and fluorescence spectra were acquired from in vivo 
epileptic and normal cortex of pediatric patients undergoing epilepsy surgery. Spectral data were 
analyzed using various statistical tools, and unique spectral features associated with epileptic 
brain tissue defined by histology and ECoG were identified. The physiological underlying 
mechanisms responsible for these spectral alterations were extrapolated.  
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3.2. Materials and Methods 
3.2.1. Instrumentation 
For this study, a portable spectroscopy system was used for acquiring fluorescence and diffuse 
reflectance spectra from the brain. The system consisted of two light sources: a pulsed nitrogen 
laser (VSL-337; Spectra Physics) for fluorescence spectroscopy and a portable halogen lamp 
(LS-1; Ocean Optics) for diffuse reflectance spectroscopy. Since data collection was performed 
in a sterile field, a sterilizable fiberoptic probe was used in conjunction with the spectroscopy 
system. The probe consisted of seven 300-micron core optical fibers, out of which two were used 
to conduct excitation light and the remaining fibers for reflected light collection. Based on the 
arrangement of the optical fibers in the probe, its volume of investigation was estimated at 
roughly 1 mm3. The collection fibers of the optical probe were connected to a spectrometer (USB 
2000-FL Spectrometer; Ocean Optics) with a spectral range of approximately 300-900 nm. The 
spectrometer was connected to a computer via a universal serial interface. A computer program 
was developed using LabView from National Instruments to control the entire spectral 
acquisition procedure.   
3.2.2. Study Procedure 
Static fluorescence and diffuse reflectance spectra were acquired from normal and epileptic brain 
areas, as defined via pre-operative imaging and ECoG studies, in pediatric patients undergoing 
epilepsy surgery. From each single patient, five or more measurement sites were selected at the 
exposed brain surface by the surgeon. These sites usually were equally distributed within and 
outside the resection zone. Prior to the spectral acquisition procedure, the investigated site was 
cleansed using saline to remove any residual blood on its surface. The optical probe was placed 
in direct contact with the cortical surface without deforming the brain surface, and three spectra 
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(i.e., baseline, fluorescence, and diffuse reflectance spectra) were acquired sequentially. Spectral 
acquisition was repeated three times, with the total time required to complete the above-
mentioned procedure less than 15 seconds. The locations of the optically-investigated sites and 
their spatial correlation with the ECoG electrode grids were documented using a digital camera. 
Biopsies were taken from the investigated sites within the zone of resection and stored in a 10% 
buffered formalin solution for subsequent histological analysis.     
3.2.3. Histological Evaluation 
All specimens collected in this study were processed in a histology lab. They were embedded in 
paraffin wax and then sectioned. From each specimen, three to four 4-micron thick sections were 
cut and stained using the conventional hematoxylin and eosin staining method. The prepared 
section was evaluated by a neuropathologist at the University of California, Los Angeles (Dr. 
Rupal Mehta). These tissue sections were assessed for architectural laminar disorder, 
cytomegaly, dysmorphism, and balloon cell change. These findings were graded from 0-3 (0-
none, 1-mild, 2-moderate and 3-severe). The presence of binucleated cells and calcification was 
also noted separately. These morphological characteristics then were used to categorize spectral 
data as either normal or histologically abnormal.  
3.2.4. Data Processing  
All spectral data acquired from the in vivo study were preprocessed to remove any artifacts 
induced by instrumentation. Mainly, baseline subtraction and calibration applications were 
performed to all acquired fluorescence spectra )(λF  and diffuse reflectance spectra )(λRd  [68]. 
Furthermore, to speed up the data analysis procedure, spectral range and resolution were further 
reduced. Specifically, diffuse reflectance data between 400 nm and 850 nm and fluorescence 
data between 380 nm and 750 nm were preserved; spectral resolution was reduced to 5 nm. In 
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addition to the individual spectral types, a combined spectrum was created for the data analysis 
process, specifically the ratio of the fluorescence and diffuse reflectance spectra (i.e.,
( )λλ (/) RdF ). The wavelength range of the combined spectra was 400 to 750 nm, and their 
resolution was 5 nm. Several normalization techniques were applied to the preprocessed spectra, 
including local maximum normalization, area under the curve normalization, global mean 
normalization, and arbitrary reference normalization (See Figure 3.1). For local maximum 
normalization, each spectrum is normalized to its maximum value. That is 
))((/)()(max λλλ SMAXSS = , where )(λS represents either )(λF , )(λRd , or )(/)( λλ RdF , and 
MAX is the maximum operation. For area-under-the-curve normalization, the new spectrum 
)(λAREAS is calculated by )(λAREAS = 
λ
λλ )(/)( SS . For global mean normalization, each spectrum 
is normalized to the mean of the total spectral data set. That is )(λMEANS = n nSS ]/)(/[)( λλ , 
where n represents the number of spectra in a single spectral dataset. Finally, arbitrary reference 
normalization produces a new spectrum using )(/)()( refPOINT SSS λλλ = , where refλ  is an 
arbitrary reference wavelength.      
3.2.5. Data Analysis and Classification Algorithm Development  
The main objective of this analysis was to determine if in vivo fluorescence and diffuse 
reflectance spectroscopy can detect histopathological and/or pathophysiological characteristics 
that are unique to epileptic brain tissue. To achieve this goal, the spectral data collected were 
classified using the results of histological analysis: the normal brain data containing spectral data 
measured from brain tissue outside the zone of resection, and the epileptic brain data containing 
spectral data from epileptic brain tissue confirmed by both histology and ECoG. To identify 
spectral regions and unique spectral features distinguishing epileptic brain tissue from normal 
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cortex, mean comparisons of the processed spectra from the two types of brain tissue (normal vs. 
epileptic) was performed for all wavelengths. Depending on the distribution and variance 
characteristics of the data, either parametric (i.e., Student’s t-test) or non-parametric tests 
(Wilcoxon Rank Sum test) were employed for mean comparisons. Next, tissue classification 
algorithms were developed based on linear discrimination analysis (LDA), for the purpose of 
determining the accuracy of using optical spectroscopy to differentiate between normal and 
epileptic brain tissue. LDA inputs were the spectral data from normal and epileptic brain.  
 
Figure 3.1: The flow chart of the data processing procedure employed in the study. 
 Spectral data at all wavelengths were used in this process to create a model of 
discrimination, and standardized canonical coefficients used to assess the importance of spectral 
data region in determining tissue type. It was important to ensure that the discrimination model 
was statistically significant in terms of distinguishing normal brain from epileptic brain; 
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therefore, only models associated with chi-square p values less than 0.05 were considered. 
Furthermore, only models with sensitivity and specificity greater than 75% were considered 
‘successful’ and reported here. Finally, tissue type classification was validated using the cross 
validation method (i.e., building the model based on all data but one variable, and predicting the 
one excluded variable).  
3.3. Results 
In this study, a total of 16 patients were enrolled, for whom demographic information is 
summarized in Table 3.1. The total number of useful investigated sites from these patients was 
84, among which 28 sites were located outside the resection zone defined by ECoG (i.e., normal 
brain) and 56 sites within the zone of resection (ZOR). The 56 sites within the ZOR were further 
divide into two subcategories in accordance with the results of histological evaluation: 30 sites 
exhibited histological features associated with epilepsy (epileptic brain), while the remaining 26 
sites did not. The distribution of sites is shown in Table 3.2.     
Spectral data analysis revealed that only those spectral differences identified within four spectral 
types (i.e., original )(λRd , )(λMEANRd , )(λPOINTRd , and )(/ λMEANRdF ) could produce 
discrimination algorithms with sensitivity and specificity greater than 75%. Analytical results for 
each spectral type follow. 
3.3.1. Original )(λRd   
Comparing the original )(λRd from normal and epileptic brain revealed significantly different 
mean )(λRd intensity between 400 and 600 nm (p < 0.05, see Figure 3.2). Inputting the Rd 
signals from this spectral band, the best classification result based on LDA was 82.1% 
sensitivity, 76.7% specificity, and 79.3% total accuracy.  
3.3.2. )(λMEANRd  
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Similar to original )(λRd , )(λMEANRd between 400 and 600 nm also was statistically different 
between normal and epileptic brain (p < 0.05, see Figure 3.3). Entering the signals from this 
spectral band, the best classification result based on LDA was 75.0% sensitivity, 83.3% 
specificity, and 79.3% overall accuracy, which is comparable to using the original )(λRd . 
Patient Number Patient Age/Gender
1 3/M
2 4/F
3 4/M
4 6/M
5 2/F
6 14/F
7 8/F
8 21/F
9 2/M
10 20/F
11 17/F
12 5/M
13 3/F
14 16/F
15 10/M
16 3/M
Table 3.1: Demographic information of the patients studied. 
 
ECoG Pathology Site #
- NA 28 
+ - 26 
+ + 30 
Table 3.2: Distribution of the investigated sites. 
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3.3.3. )(/)( refRdRd λλ  
Analyzing )(/)( refRdRd λλ , as shown in Figures 3.4 and 3.5, revealed several spectral features 
that could effectively differentiate normal from epileptic brain. Most of these spectral features 
were evident between refλ  = 400 and refλ = 600 nm. Entering these identified spectral features, 
classification results based on LDA were ~75% sensitivity and ~80% specificity (Table 3.2). 
Discrimination was optimized when refλ was 505 nm, where the overall accuracy of the 
discrimination algorithm was 86.2%. 
3.3.4. )](/)(/[)](/)([ refref RdFRdF λλλλ    
Analysis of )](/)(/[)](/)([ refref RdFRdF λλλλ , as shown in Figures 3.6 and 3.7, also revealed 
several spectral features from the combined spectrum that could effectively distinguish normal 
from epileptic cortex. Again, the majority of these spectral features were located between refλ  = 
400 and refλ  = 600 nm. Entering the identified spectral features, classification results based on 
LDA yielded sensitivity above 75% and specificity above 80% (Table 3.3). Discrimination was 
optimized when refλ was 485 nm, where the overall accuracy of the discrimination algorithm was 
96.6%.   
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(a) 
 
(b) 
(c) 
Sensitivity: 82.1% 
Specificity: 76.7% 
Total Correct 
Classification: 79.3% 
Figure 3.2: (a) The black solid line represents the mean original Rd(λ) from the normal brain 
group, and the solid pink line the epileptic brain group.  The error bars represent one standard 
deviation of the mean.  p value is below 0.05 between 400 and 600 nm.  (b) Statistical mean-
comparison of original Rd(λ) between normal and epileptic brain. (c) The optimal performance 
of the classification based on LDA, using original Rd(λ)  as the inputs, was sensitivity = 82.1%, 
specificity = 76.7%, and total correct classification = 79.3%.  
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(a) 
 
 
(b) 
(c) 
Sensitivity: 75% 
Specificity: 83.3% 
Total Correct 
Classification: 79.3% 
Figure 3.3: (a) The black solid line represents the mean RdMEAN(λ) from the normal brain group, 
and the solid pink line the epileptic brain group.  The error bars represent one standard 
deviation of the mean.  p value is below 0.05 between 400 and 600 nm.  (b) Statistical mean-
comparison of RdMEAN(λ) between normal and epileptic brain. (c) The optimal performance of 
the classification based on LDA, using RdMEAN(λ) as the inputs was sensitivity = 75%, specificity 
= 83.3%, and total correct classification = 79.3%.  
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Figure 3.4: (a) Surface plot of the p_values from the mean-comparison of Rd(λ)/Rd(λref) between 
normal and epileptic brain.  (b) Representative test results with reference wavelength λref  = 505 
nm.  The blue solid line represents the mean Rd(λ)/Rd(λref)  of the normal brain group, and the 
blue dash line the epileptic brain group.  Statistically significant differences (p < 0.05) are found 
between 425 nm and 460 nm and 535 nm and 575 nm in this case. 
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Figure 3.5: Surface plot of the p-values from the mean comparison of Rd(λ)/Rd(λref) from the 
normal and the epileptic cortex group.  Each data column in this surface plot represents the line-
plot shown in Figure 3.4.  
 
 
λref (nm) Sensitivity (%) Specificity (%) Total Correct Classification (%)
445 75 86.7 81 
455 75 80 77.6 
460 75 83.3 79.3 
500 78.6 90 84.5 
505 82.2 90 86.2 
535 78.6 86.7 82.8 
550 78.6 86.7 82.8 
605 78.6 86.7 82.8 
Table 3.3: Classification results of the discrimination algorithms based on LDA using 
Rd(λ)/Rd(λref) as the inputs.   
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Figure 3.6: Representative statistical mean comparison of [F(λ)/Rd(λ)]/[F(λref)/Rd(λref)] from the 
normal and epileptic groups. Here λref is 485 nm.  The blue solid line represents the mean 
spectrum of the normal group, and the blue dash line the epileptic group. The statistically 
significant differences (p < 0.05) are found between 430 nm - 450 nm as well as 625 nm - 660 
nm. 
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Figure 3.7: Surface plot of p values from the mean comparison of [F(λ)/Rd(λ)]/[F(λref)/Rd(λref)] 
from normal cortex and epileptic cortex.  Each data column in this surface plot represents the 
line-plot shown in Figure 3.6. 
 
λref (nm) Sensitivity (%) Specificity (%) Total Correct Classification (%) 
400 75.0 83.3 79.3 
420 75.0 86.7 81.0 
455 89.3 86.7 87.9 
485 92.9 100.0 96.6 
500 85.7 90.0 87.9 
505 89.3 90.0 89.7 
510 89.3 90.0 89.7 
520 92.9 90.0 91.4 
Table 3.4: Classification results of the discrimination algorithms based on LDA, using 
[F(λ)/Rd(λ)]/[F(λref)/Rd(λref)] as the inputs.   
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3.4. Discussion 
The in vivo study results reported in this chapter demonstrate that in vivo static diffuse 
reflectance spectroscopy, as well as its combination with static fluorescence spectroscopy, can be 
used to effectively differentiate epileptic brain (as defined by ECoG and histology) from normal 
brain with a high degree of accuracy. The most effective discrimination algorithm is derived 
using the spectral features from )]485(/485(/[)](/)([ nmRdnmFRdF λλ , where discrimination 
accuracy reaches 96.6%. This supports the concept of developing a new intraoperative guidance 
system based on optical spectroscopy, to detect histopathological abnormalities associated with 
epileptic brain in the operating room and, thereby, provide additional information to aid in the 
demarcation of epileptic foci.  
 Using parametric and non-parametric statistical comparison methods, original )(λRd , 
)(λMEANRd , and )(/)( refRdRd λλ between 400 and 600 nm were found to be significantly 
different in epileptic versus  normal brain. Since diffuse reflectance spectra in this region are 
heavily influenced by hemoglobin absorption, this finding implies that certain static 
hemodynamic characteristics of epileptic cortex, in particular hemoglobin concentration and 
hemoglobin oxygenation, are very different from that of normal cortex. Previous studies have 
shown that hypometabolism and hypoperfusion are frequently observed in the area of an 
epileptic focus and its immediate surroundings in the brain of patients with partial seizures [104-
109]. In addition, Stefanovic et al pointed out that normal interictal neurovascular coupling is 
progressively compromised by sustained seizure attacks [109]; Schwartz suggested that epileptic 
cortex generally receives inadequate cerebral blood flow [75]. However, alterations in resting 
state hemodynamics may not exist in all types of refractive epilepsy. It has been shown that 
average resting metabolism and blood flow are largely unremarkable in patients with idiopathic 
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generalized epilepsy [110-112]. Because of significant differences in the discharge 
characteristics of ictal versus interictal states, it has been suggested that the cerebral blood flow 
and cerebral metabolic rate of oxygen changes induced by interictal discharges may be far less 
noticeable than their ictal counterpart [104, 111, 113]. This implies that the changes in diffuse 
reflectance signals reported here are not necessarily associated with the presence of interictal 
discharges. The results of this study further suggest that histological abnormalities may be linked 
to changes in regional resting state hemodynamics. It is possible that histological abnormalities 
like cortical dysplasia modify the characteristics of astrocytic Ca2+ oscillations, which, in turn, 
alter astrocytic function regulating cerebral blood vessel diameters and, hence, regional 
hemodynamics [114-118]. More studies, however, will have to be conducted to verify such 
conjectures. 
 When illuminated by an excitation light at 337 nm, the intrinsic fluorescence signal 
collected from brain tissue between 450 nm and 500 nm emission is believed to originate 
primarily from NAD(P)H. This assumption is based upon two factors: (1) NAD(P)H has a 
relatively high quantum yield relative to other biological fluorophores at the same excitation 
wavelength; and (2) the concentration of NAD(P)H is very high in the brain, due to brain’s high 
metabolism. Several studies have shown that the metabolic activities of any in vivo biological 
tissue, including brain, may be monitored through NAD(P)H fluorescence [74, 99].  Since 
epileptic cortex is hypo-metabolic [104-109], it has been hypothesized that fluorescence 
spectroscopy may be used to detect this characteristic of epileptic brain. However, the study 
results reported here do not support this hypothesis; the intrinsic fluorescence spectra (337 nm 
excitation) from epileptic brain were not significantly different from those of normal brain. One 
possible explanation for this inefficiency is that fluorescence signals measured from in vivo brain 
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are heavily modulated by its absorption (i.e., hemoglobin concentration and hemoglobin 
oxygenation) as well as scattering properties. In order to truly verify the usefulness of NADH 
fluorescence at detecting epileptic cortex, intrinsic fluorescence quantity must be retrieved using 
complex spectral processing techniques [76].        
 The results of the current study are promising, but only preliminary in nature. Several 
obstacles must be overcome before the clinical value of optical spectroscopy, namely 
fluorescence and diffuse reflectance spectroscopy, is clarified for demarcating epileptic foci and, 
hence, aiding epilepsy surgery. The most important challenge is the lack of a gold standard for 
defining epileptic brain. While optical spectroscopy can indirectly detect histological 
abnormalities of epileptic brain, it is not yet proven that these histological features provide better 
demarcation than ECoG. Furthermore, this study also revealed considerable discrepancies 
between the results of ECoG and those of histological study. On many occasions, the brain area 
classified as abnormal by ECoG was interpreted as histologically normal by our 
neuropathologist. This may be attributed to the fact that the optical probe we used in this study 
has a limited depth of investigation (less than 1 mm). Therefore, optical investigation was 
performed only on the superficial layer of the cortical surface; histopathological abnormalities 
present in the deeper layers of the cortex could be missed by either optical spectroscopy or 
biopsy. Another possible explanation is that conventional histological methods cannot detect 
molecular alterations underlying the abnormal electrical activities of epileptic cortex. Also, it is 
possible that the origin of interictal spikes may not be the same as that defined by ECoG due to 
electrical spreading. Finally, it will be challenging to establish a universal normal baseline for the 
diffuse reflectance and fluorescence spectra of normal pediatric cortex, because the brain 
undergoes development and increases in size and weight significantly throughout childhood. To 
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address the challenges mentioned above, a new probe should be engineered to investigate various 
layers of cortex for abnormalities associated with epilepsy.  Moreover, a dynamic spectroscopy 
system that is capable of continuously recording fluorescence and diffuse reflectance spectra 
from the in vivo brain at a high rate (> 15 Hz) should be developed and used.  Such a system will 
allow us to gain insights into the dynamic natures of epileptic cortex during the interictal state, 
which could yield a better spectral discriminant.  These new developments will be reported in the 
following chapters. 
3.5. Conclusions 
The feasibility of using diffuse reflectance and fluorescence spectroscopy to aid epilepsy surgery 
in children was investigated. Static diffuse reflectance and fluorescence data were collected from 
abnormal cortex, as defined by pathology and ECoG. Tissue discrimination algorithms with high 
sensitivity and specificity were produced using various spectral features. The success of this 
study warrants a future large-scale study to verify the potential role of optical spectroscopy in 
pediatric epilepsy surgery.  
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4. Design and Develop a Portable Dynamic Spectroscopy System for In Vivo Epileptic 
Brain Study  
4.1. Introduction 
Fiberoptic spectroscopy systems are commonly used in optical diagnostic studies [119, 120].  
However, they often are used to capture the static natures of in vivo tissue.  Since the brain is a 
dynamic organ and the epileptic brain processes several unique temporal physiological 
characteristics, it is important to improve the optical spectroscopy system described in chapter 3 
to capture these unique features and hence, maximize the efficiency of optical spectroscopy in 
detecting epileptic cortex intraoperatively.  In this chapter, details about the design and 
development of a new dynamic spectroscopic system for in vivo study of the epileptic brain are 
presented.   
4.2. Optical Probe Design and Development  
One major task of the instrumentation update was to optimize the design of the optical probe. 
The arrangement of the optical fibers within an optical probe influences the collection efficiency 
of reflected light (i.e., signal to noise ratio) and, more importantly, the volume and the depth of 
investigation.  As mentioned before, histopathological studies of epileptic cortex have shown that 
structural abnormalities associated with epilepsy may exist in the deeper layers (2 to 4 mm) of 
the cortex. Therefore, it is critically important to understand the design parameters of the fiber 
optical probe, mainly the distance between the source fiber and the collection fiber (i.e., source-
detector separation), influence the depth of investigation and signal to noise ratio. To gain this 
insight, a computer simulation model for photon migration, Monte Carlo simulation, was 
developed and used.  
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4.2.1. Materials & Methods 
Monte Carlo simulation for photon migration is a popular tool to study light propagation and 
distribution in biological tissues (i.e., scattering-absorbing media).  The mathematical algorithms 
of the MC simulation can be found elsewhere [121]. To speed up the development process, the 
new simulation code was developed using a MC simulation model previously developed by Dr. 
Wei-Chiang Lin (WCLMC).  WCLMC was derived from the source codes written by Dr. Andy 
Dunn, University of Texas at Austin, as well as those written by Dr. Steve Jacques and Lihong 
Wang at MD Anderson Cancer Center. WCLMC simulates the steady state photon distribution 
within and outside a multilayered tissue slab (i.e., diffuse reflectance, fluence rate, and diffuse 
transmittance), illuminated by a light source at an arbitrary incident angle.   
In order to adapt WCLMC for the needs of the probe design study, the following modifications 
were performed.  
(I) The location and the diameter of the detection fiber can be specified by the user.  
When a photon package is launched by the source fiber (centered at the origin), its 
trajectory within the simulated tissue will be recorded and preserved, if its exit 
location is within the area of detection determined by the detection fiber.  
(II) The collection of reemitted photons is exit angle dependent.  This modification takes 
the finite numerical aperture of an optical fiber into consideration.  Also, it provides 
the capability of designing an optical probe with tilted optical fibers, which can 
control the depth of investigation in an optical diagnosis application [122, 123]. 
(III) The weight deposition (i.e., energy absorption) by a photon package, while it is 
traveling within the simulated tissue, is registered (see Figure 4.1).  In this simulation 
model, weighted photon (i.e., photon package) is used and its initial weight is 1.   
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(IV) The weight deposition is registered 3-dimensionally.  The tissue slab was divided into 
an array of voxels whose dimensions (i.e., dx, dy, and dz) are defined by the user.  
This setup facilitated layer wise summation of photon weight deposition, which, in 
turn, provides knowledge about the contributions of individual layers to the detected 
signal (see Figure 4.2).  
 The modified WCLMC was called ProbeMC, and its flow chart is depicted in Figure 4.3. 
Since brain cortex has a layer wise structure [124, 125], ProbeMC was designed to handle such a 
characteristic.  Specifically, the simulated tissue in ProbeMC may have an arbitrary number of 
layers; each layer is homogenous and has a unique thickness and optical properties.  The width 
of the simulated tissue is infinite in general.  Optical properties of each layer used in the 
simulations for the probe design study were those from human gray and white matter (see Table 
4.1) [126-129].  An example input file of ProbeMC is provided in Table 4.2.  Finally the number 
of photons used in each simulation was sufficiently large (e.g., 10 million) to smooth out the 
statistical noises associated with the MC simulation.  ProbeMC was computationally intensive; 
therefore, several multi-core personal computers were used to complete the simulation work 
needed to complete the probe design study. The simulation results were displayed in 3D using 
Voxler software from Scientific Software Group.  The accuracy of ProbeMC was confirmed by 
comparing its results with those produced by WCLMC using identical input parameters.    
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(a) 
 
(b) 
 
Figure 4.1: (a) A 2-D illustration of multiple photon trajectories within the simulated tissue.  
The symbols represent the locations of photon energy deposition. (b) Weightwise display of a 
photon package migrating from the source fiber to the detector fiber.  Here white color denotes 
the weight of the photon package is 1; black is 0. 
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Figure 4.2: Illustration of an example grid cell (voxel) centres used to record photon weight 
deposition in ProbeMC. 
 
850 nm Thickness (cm) mua (cm-1) mus (cm-1) g 
Layer 1 0.4 0.47 67 0.9
Layer 2 1.6 1 342 0.88
450 nm Thickness (cm) mua (cm-1) mus (cm-1) g 
Layer 1 0.4 0.7 117 0.88
Layer 2 1.6 1.4 420 0.78
Table 4.1: Optical properties of the simulated brain tissue at 450 nm and 850 nm.  Here Layer 1 
represents the cortex and Layer 2 the white matter. 
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Figure 4.3: Flowchart of ProbeMC developed in house for the probe design study. 
  
Input Parameters: 
Source radius, Detector radius, Detector location, 
Properties of tissue, Exit angle and No of photons 
 Launch photons 
Absorption, Scattering, 
increment pathlength 
by step size 
Generate step size  
 
 Hit detector 
 surface 
 
Store in an array: 
Photon Trajectory, 
Weight Loss, 
Exit Angle 
End 
Yes 
No 
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Number of Layer 2 
Refractive index of the incident medium 1 
 Layer 1 Layer 2 
mus See Table 4.1 
mua 
g 
Thickness 0.4 1.6 
Refractive index 1.4 1.4 
Refractive index of the back medium 1 
Number of photons 10,000000 
Number of x grids 1 
dx 4 
Number of y grids 1 
dy 4 
Number of z grids 20 
dz 0.1 
beam radius (cm) 0.015  
X coordinate of detector 0.090 
Y coordinate of detector 0 
Detector Radius  0.015 
Table 4.2: Representative input file for ProbeMC.   
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4.2.2. Results  
4.2.2.1. Signal Strength vs. Source Detector Separation 
Figure 4.4 shows the simulated relationship between the diffuse reflectance intensity and the 
source detector separation (S-D), using the brain model depicted in Table 4.1.  Clearly diffuse 
reflectance decreases quickly when S-D increases; the rate of decrease with S-D < 1 mm is much 
greater than that with S-D > 1 mm.  Comparing the relationships at 450 nm and 850 nm, it was 
noticed that the rate of decrease in diffuse reflectance intensity is slower at 850 nm than that at 
450 nm.  This indicates that the S/N ratio of the diffuse reflectance signal at 450 nm will suffer 
more significantly than that at 850 nm when S-D increases.    
  
Figure 4.4: Diffuse reflectance intensity (W/cm2) at 450 nm and 850 nm as a function of source-
detector separation (S-D). 
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4.2.2.2. Weight Deposition vs. Source Detector Separation 
Figure 4.5 depicts the relationship between the layerwise photon weight deposition and source 
detector distance at 450 nm.  Here, the majority of the photon weight deposition takes place 
within the first layer (i.e., 0 to 0.1 cm).  In other words, the first 0.1 cm of the simulated tissue 
sample dictates the magnitude of the diffuse reflectance signal at 450 nm.  As the source detector 
separation increases, the percentage weight deposition in layer 2 increases steadily (i.e., making 
a stronger influence to the signal detected).  However, the effect of SD on the weight deposition 
in layers 3 and beyond is minimal.  Therefore, diffuse reflectance signals at 450 nm will not be 
sensitive to the optical characteristics of the cortex beyond 2 mm below the surface.   
Figure 4.6 depicts the relationship between the layerwise photon weight deposition and S-D at 
850 nm.  The majority of the photon weight deposition takes place within the first five layers 
(i.e., 0 to 0.5 cm) of the simulated tissue.  In other words, the first 5 mm of the tissue sample 
strongly dictates the magnitude of the diffuse reflectance signal at 850 nm.  As S-D increases, the 
relative weight deposition in layers 2 to 5 increases steadily (i.e., making a stronger influence to 
the signal detected).   
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Figure 4.5a: Photon weight deposited in the individual layer as a function of S-D.  Each line 
represents a unique S-D (specified in the legend).  Optical properties at 450 nm were used in this 
set of simulations. 
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Figure 4.5b: Percentage contribution of individual layer to the overall weight deposition (i.e., 
the reduction in the detected diffuse reflectance signal) as a function of S-D.  Each line 
represents a unique S-D (specified in the legend).  Optical properties at 450 nm were used in this 
set of simulations. 
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Figure 4.6a: Photon weight deposited in the individual layer as a function of S-D.  Each line 
represents a unique S-D (specified in the legend).  Optical properties at 850 nm were used in this 
set of simulations. 
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Figure 4.6b: Percentage contribution of individual layer to the overall weight deposition (i.e., 
the reduction in the detected diffuse reflectance signal) as a function of S-D.  Each line 
represents a unique S-D (specified in the legend).  Optical properties at 850 nm were used in this 
set of simulations. 
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4.2.3. Conclusions 
As mentioned earlier, the histopathological features of epileptic cortex could be present at all 
layers of the cortex.  Therefore, it is important to design an optical probe that can investigate the 
abnormality 4 mm beyond the cortical surface.   According to the simulation results presented in 
the previous section, the depth of the investigation can be easily controlled by modifying the 
source-detector separation.  Because of the highly absorbing and scattering nature of the cortex 
in the shorter wavelength region (i.e., < 600 nm), it is difficult to investigate deep tissue 
abnormality using diffuse reflectance signals in this wavelength band, regardless of what the 
source-detector separation is.  In this longer wavelength region (i.e., > 600 nm), the efficiency of 
using diffuse reflectance signal to investigate the deep cortical abnormalities increases as the 
source detector separation increases.  However the trade-off of increasing the source detector 
separation is the signal to noise level (S/N) is going to decrease significantly (see Figure 4.4).  
To meet the needs of high S/N as well as deep tissue investigation, it is important to keep the 
source-detector separation greater than 600 µm but smaller than 1000 µm, and the illumination 
should be beyond 600 nm. 
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4.3. Dynamic Spectroscopy System Design and Development  
4.3.1. Introduction 
The spectroscopic system used in the in vivo brain studies (see Chapter 3) was designed to 
capture the static nature of the investigated tissue.  The existing knowledge about pediatric 
epileptic cortex leads one to believe that a wealth of diagnostic information about epileptic 
cortex may be found in the temporal variations of their intrinsic characteristics such as 
metabolism and hemodynamics.  Therefore, it was the goal of this study to convert the existing 
static spectroscopy system (i.e., F(λ) and Rd(λ)) into a dynamic one (i.e., F(λ,t) and Rd(λ,t)).  In 
order to perform time dependent measurements, it was instrumental to have a stable light source 
that provides stable excitation light.  Due to its pulsed nature and limited repetition rate (i.e., 20 
Hz), the nitrogen laser was deemed not suitable for the time dependent fluorescence 
spectroscopy study.  The ideal replacement for the nitrogen laser would be CW UV lasers, but 
they are priced beyond the budget of the project.  Therefore, the upgrade of the system only 
focused on the diffuse reflectance spectroscopy part.  To achieve this goal, the following 
upgrades were planned:   
(1) A sensitive spectrometer should be used to reduce the time required to acquire a 
single spectrum (i.e., integration time).  Here the target integration time was 30 ms, 
which would yield a 33 Hz spectral acquisition rate matching with the frequency band of 
alpha waves.  
(2) A powerful broadband light source with a high temporal stability should be used.  The 
output power of the light source should be high enough to maintain the S/N of the 
acquired spectra above 20 and, at the same time, low enough not to induce thermal 
damage to the tissue.     
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(3) A fast controller with a larger memory capacity (i.e., more RAM) should be used to 
reduce the time required to write the spectral data to the hard drive during an acquisition 
procedure.  The memory should be sufficiently large in order to allow continuous spectral 
acquisition for at least 12 seconds (i.e., 400 spectra) per investigation.       
4.3.2. Materials and Methods 
In order to perform the continuous diffuse reflectance spectral acquisition, the controller 
software was modified first. The modification allowed users to specify (1) the spectral 
acquisition rate (# of spectra per second), (2) the recording duration (total # of spectra acquired), 
and (3) the integration time for each spectral acquisition.  To reduce the overhead resulting from 
directly writing the spectral data to the hard drive of the controller, the acquired spectra were 
stored in the RAM (4 GB) first and then saved to the hard drive upon completion of a single 
investigation.   
 To determine the applicability of the existing components in the static spectroscopy 
system for the time dependent spectroscopy measurements, the following studies were designed 
and carried out. 
1. Quantify the noise level and characterize the noise characteristics ns(λ,t) of the existing 
spectrometer (USB2000, OceanOptics).  The main purpose of this sub-study was to determine 
the magnitude and the frequency spectral composition of the spectrometer noise.  The static 
spectroscopy system was used to acquire diffuse reflectance spectra from a non-biological 
subject (e.g., a piece of printer paper) without using the excitation light.  The integration time 
was set at 30 ms, 100 ms, and 500 nm and the total number of the spectra acquired were 400.  
This experiment procedure was repeated twice: one without using the built-in boxcar smoothing 
function and the other with.  The acquired spectra were preprocessed to reduce their spectral 
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resolution to 5 nm.  The time history of the diffuse reflectance signal at a given wavelength 
(Rd(λa,t)) was retrieved from the data set.  To analyze the temporal variation Rd(λa,t) during the 
recording period, the standard deviation of Rd(λa,t) was calculated. Furthermore, the distribution 
characteristics of Rd(λa,t) were reviewed using histogram analysis.  Finally the frequency 
spectral composition of Rd(λa,t) was analyzed using Fourier transformation.    
2. Quantify the noise level and the stability from the light source. The main purpose of this sub-
study was to determine the noise originating from the excitation light source as well as its output 
stability. The spectroscopy system was used to acquire diffuse reflectance spectra from a non-
biological sample (e.g., a piece of printer paper) with the excitation light turned on.  The 
integration time of the spectroscopy system was set at 30 ms and the total number of spectra 
acquired was 400.  The spectral acquisition was carried out after a fixed amount of the heating 
time of the white light source.  The heating time used in this study was 0 second, 30 seconds, 40 
seconds, 1 minute, 2 minutes, 3 minutes, 4 minutes, and 5 minutes.  The boxcar smoothing 
function was used in this study.  The acquired spectra were preprocessed to reduce their spectral 
resolution to 5 nm.  The time history of the diffuse reflectance signal at a given wavelength 
(Rd(λa,t)) was retrieved from the data set.  To analyze the effects of the heating time on the 
temporal variation Rd(λa,t), the standard deviation of Rd(λa,t) was calculated and plotted as a 
function of the heating time. Furthermore, the distribution characteristics of Rd(λa,t) was 
reviewed as a function of heating time using the histogram analysis.  Finally the frequency 
spectral composition of Rd(λa,t) was analyzed as a function of the heating time using Fourier 
transformation.    
 Using the data from the light source stability evaluation, the S/N of the diffuse 
reflectance spectra at various signal strength levels was also evaluated. Here the mean value of 
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Rd(λa,t) was calculated (Rd mean (λa)) and subtracted from Rd(λa,t) to yield the noise component 
of Rd(λa,t) (Rdnoise(λa,t)).  Finally, the S/N(λa) was calculated by Rd mean (λa)/STD(Rdnoise(λa,t)), 
where STD is the calculation of standard deviation.  The S/N(λa) was evaluated between 400 and 
850 nm, where the main diffuse reflectance spectral band was, and its relationship with the 
magnitude of the signal was determined.   
4.3.3. Results  
4.3.3.1. Spectrometer Noise Analysis 
A typical Rd(λa,t) recorded without excitation light is shown in Figure 4.7, and its corresponding 
frequency spectrum is shown in Figure 4.8.  Since the excitation light and the ambient light were 
off, Rd(λa,t) recorded under such a condition represents the spectral signal (i.e., noise spectrum 
NS(λa,t)) originating from the spectrometer itself.  It is noted that there are two components in 
the NS(λa,t) of the spectrometer: a DC component and an AC component.  The DC component is 
believed to be originated from the dark current of the detector of the spectrometer and is 
wavelength and time independent. Therefore, it can be easily estimated by calculating the mean 
of NS(λa,t).  The AC component of NS(λa,t) is a random fluctuation; its frequency spectrum 
suggests that it strongly resembles white noise (i.e., the power spectral density is relative uniform 
over the entire frequency spectral range).  The histograms of the AC component (Figure 4.9) 
suggest that the magnitude of this random fluctuation has normal distribution characteristics.  
The maximum and minimal magnitudes of the AC component are about + 9 and – 9, 
respectively, and they are wavelength and integration time independent (Figure 4.10).  The 
standard deviation of the AC component is about 3, which is also wavelength and integration 
time independent (Figure 4.11).  Since the maximal spectral intensity of the existing 
spectrometer is 4096 au; the maximum signal to noise ratio of the diffuse reflectance spectra 
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recorded would be S/N = 4096 au/18 au = 227.  In order to maintain the signal to noise level 
above 20, the true signal in Rd(λa,t) has to be greater than 360 au. 
 The application of the real-time boxcar smoothing significantly reduces the AC 
components in NS(λa,t), as shown in Figures 4.12 and 4.13, as well as the magnitude of its 
frequency components.  According the mean and standard deviation calculation of smoothed 
NS(λa,t) shown in Figures 4.8 and 4.9, the smooth function effectively provides a 10-fold 
reduction of the spectrometer noise.  More importantly, the boxcar smoothing can be performed 
in real time and hence does not affect the goal of continuously acquiring diffuse reflectance 
spectra at 33 Hz. It also allows detection of weak fluctuations in diffuse reflectance signals 
resulting from the regional alterations in physiological characteristics of the investigated tissue.     
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Figure 4.7: Rd(λa,t) at λa = 400, 600, and 800 nm.  The integration time is 30 ms, and the total 
number of spectra acquired (i.e., the number of data points along the time axis) is 400.   
 
Figure 4.8: Frequency spectra of Rd(λa,t) at λa = 400, 600, and 800 nm.  The integration time is 
30 ms.   
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Figure 4.9: The histograms of the AC component of NS(λa,t) at λa = 400, 600, and 800 nm. 
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Figure 4.10: The difference between Max and Min of NS(λa,t) (i.e., Max(NS)-Min(NS)) within a 
single recording period between 400 and 850 nm. The legend indicates the integration time used.    
 
 
Figure 4.11: The standard deviation of NS(λa,t) within a single recording period as a function of 
wavelength. The legend indicates the integration time used.     
 
400 500 600 700 800
14
16
18
20
22
R
an
ge
 (A
.U
.)
Wavelength (nm)
 
 
30ms
100ms
500ms
400 500 600 700 800
2.6
2.7
2.8
2.9
3
3.1
3.2
ST
D
Wavelength (nm)
 
 
30ms
100ms
500ms
56 
 
 
Figure 4.12: Smoothed Rd(λa,t) at λa = 400, 600, and 800 nm.  The integration time is 30 ms, 
and the total number of spectra acquired is 400.  Here boxcar smoothing with a window size of 
20 was used to smooth the individual spectrum (i.e., Rd(λ)).  The smoothing was performed in 
real-time during the spectral acquisition.  
 
Figure 4.13: Frequency spectra of smoothed Rd(λa,t) at λa = 400, 600, and 800 nm.  The 
integration time is 30 ms, and the total number of spectra acquired is 400.  Here boxcar 
smoothing with a window size of 20 was used to smooth the individual spectrum (i.e., Rd(λ)).  
The smoothing was performed in real-time during the spectral acquisition. 
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Figure 4.14: The difference between Max and Min of the smoothed NS(λa,t) (i.e., Max(NS)-
Min(NS)) within a single recording period between 400 and 850 nm.  The legend indicates the 
integration time used.   
 
Figure 4.15: The standard deviation of the smoothed NS(λa,t) within a single recording period as 
a function of wavelength. The legend indicates the integration time used.   
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4.3.3.2. Light Source Characteristics 
Since the new spectroscopy system aims to investigate temporal variations in the physiological 
characteristics of the brain, it is instrumental that the light source does not introduce additional 
noise to the recorded spectra.  The light source used in the new spectroscopic system is a CW 
tungsten light source; therefore, the main source of the noise would be the drifting of the output 
power of the light source.  As shown in Figures 4.16 and 4.17, the output power of the light 
source is dependent of the heating time allowed.  Immediately after the white light source is 
turned on, it is noticed that Rd(λa,t) steadily decreases as a function of time and this decline trend 
is wavelength independent.  This indicates that the overall output power of the light source 
decreases gradually during the initial operation. The existence of this declining trend 
significantly increases the low frequency component of Rd(λa,t), which could overwhelm slow-
varying physiological signals such as low frequency hemodynamic oscillation.  Thirty seconds 
after the light source was turned up, it is noticed that the drifting of Rd(λa,t) became much less 
significant and the output power of the light source reached a steady state.    When the light 
source is allowed to heat up for at least 30 seconds, the noise characteristics of Rd(λa,t), which is 
the AC component of Rd(λa,t), is comparable to that of the spectrometer in terms of magnitude, 
magnitude distribution, and frequency composition. 
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Figure 4.16: Time history of Rd(λa,t) at λa = 400, 600, and 800 nm. Heating time is (a) 0 second, 
(b) 30 seconds, (c) 1 minutes, and (d) 5 minutes.  Note the mean value of Rd(λa,t) within one 
recording period was subtracted from Rd(λa,t) in these plots.   
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Figure 4.17: Frequency spectra of Rd(λa,t) at λa = 400, 600, and 800 nm. Heating time is (a) 0 
second, (b) 30 seconds, (c) 1 minutes, and (d) 5 minutes. 
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4.4. Discussion and Conclusions 
The probe design analysis shows that the source detector separation in a fiberoptic probe designs 
strongly influences the sensitivity of the measured diffuse reflectance signals to the variations at 
different depth of the cortex.  While increasing the source detector separation allows detection of 
deep abnormality within the cortex, the trade-off is low S/N, which is especially severe in the 
wavelength region where the scattering and absorption properties are high.  Furthermore, this 
trade-off would significantly impact the capability of performing high speed time dependent 
diffuse reflectance spectral acquisition from the cortex.   It is found that the optical probe 
designed for the static spectroscopy system provides an investigation depth of ~ 1 mm, which 
encompasses the second and the third layers of the cortex.  Since the dynamic measurement aims 
to probe the hemodynamics of the cortex and the vascular density in layer two and three of the 
cortex is large, it is possible to use the existing optical probe to investigate the hemodynamic 
characteristics of the epileptic cortex as a function of time.   
 The noise analysis of the spectrometer and the light source reveals distinct noises 
characteristics for each device.  The spectrometer contributes two types of noises: a DC one 
originating from the dark current of the detector and an AC one similar to the white noise.  The 
DC noise of the spectrometer is wavelength and integration time independent, and can be easily 
removed by subtracting the mean from the recorded signal.  The AC component is random and 
has a broad frequency spectral band (i.e., white noise) and cannot be removed using the 
conventional filtering techniques. Nevertheless, the results of the noise study show that 
smoothing the diffuse reflectance spectra using a boxcar filter significant reduces the magnitude 
of the AC component of the spectrometer noise.  Therefore it is possible to utilize this filter in 
real time to reduce the noise introduced by the spectrometer in the recorded data.  The noise from 
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the light source, on the other hand, is a low frequency one: the output power of the light source 
decreases gradually during the first 30 seconds of the operation and then reaches a steady state.  
In order to avoid the interference of output instability of the light source to the time dependent 
diffuse reflectance signal records, it is recommended that the light source should be turned on at 
least 30 seconds prior to a single spectral acquisition process.  In conclusion, the analysis 
performed in this chapter provides valuable insights into the construction of a time dependent 
diffuse reflectance spectroscopy system for in vivo epileptic cortex study.  More importantly, it 
suggests that the static spectroscopy system (the diffuse reflectance part) could be used to 
investigate the hemodynamic characteristics of the human cortex with some modifications to the 
data acquisition software and hardware designs of the controller and the system.  These 
modifications were carried out and the dynamic system was used in another in vivo human study.  
Details about this study can be found in the next chapter.         
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5. Improving the quality of time-dependent, diffuse reflectance spectroscopic signals 
measured from in vivo brain during craniotomy by reducing motion artifacts 
5.1. Introduction 
Spectroscopy-based optical diagnostic technologies have been investigated and evaluated widely 
over the past two decades; they are primarily used to detect pre-cancer in various tissue organs 
[93, 130-134] and guide tumor resection intraoperatively [51, 69, 135, 136]. These technologies 
are built upon the principle of light-tissue interactions: light absorption and scattering inside a 
biological tissue are governed by the tissue’s structural and compositional characteristics and 
these intrinsic characteristics are altered by disease and/or injury [133, 137-141]. These 
technologies hold several advantages over existing diagnostic technologies, in that they are 
relatively inexpensive, highly portable, and can be used real-time.  To make these technologies 
applicable within an in vivo or intraoperative environment, a sterilized contact probe often is 
employed to achieve remote sensing from in vivo tissue.  The probe typically is held by the hand 
of an operator.  One common problem with such a practice is motion artifacts in the acquired 
data. Unintentional hand movements or tremors alter the pressure of the probe against the target 
tissue or shift the site of investigation. Ultimately, these movements are incorporated into the 
data as noise or artifacts. A couple of earlier reports have suggested that probe pressure does not 
significantly affect fluorescence intensity of the cervix [143, 144]. A similar finding was noted in 
a study in which Raman spectroscopy was used to detect pre-cancerous lesions within the 
gastrointestinal tract [145].  However, several other studies have shown that excessive probe 
contact pressure, resulting from hand movements, can lead to strong alterations in the 
hemodynamic and metabolic characteristics of local tissue [146-151].  In addition, the effect of 
varying probe contact pressure on acquired optical spectral data is tissue type dependent: the 
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softer the tissue, the greater the effect [142].  Despite this recognition, the intrinsic characteristics 
of the spectral artifacts induced by hand motions have not yet been thoroughly investigated, and 
no systematic approach to combat this obstacle has been proposed.     
 In this paper, we report the results of an in vivo study of the brains of pediatric patients 
undergoing epilepsy surgery, so as to quantify the spectral and temporal artifacts induced by 
hand motions. Specifically, time-dependent diffuse reflectance spectra were acquired from the 
normal cortex of patients during epilepsy surgery using a fiber-optic spectroscopy system.  Two 
distinct methods of spectral data acquisition were compared: one with the fiber-optic probe held 
by the surgeon’s hand during data acquisition, and the other with the probe held by a mechanical 
probe holder. The probe holder was devised to eliminate hand-motion artifacts in the recording 
and to counteract any spontaneous movements of the in vivo brain. Recordings from the two 
data-acquisition methods were compared in the time, frequency, and wavelength domains, using 
both descriptive and inferential statistics. From these results, the characteristics of spectral 
artifacts induced by hand movements were determined and characterized. 
5.2. Materials and Methods 
5.2.1. Instrumentation 
The instrumentation for in vivo diffuse reflectance spectral acquisition consisted of a fiber-
optical probe and a portable spectroscopic system. It was calibrated using a calibrated tungsten 
halogen light source (LS-1-CAL, Ocean Optics, Dunedin, FL) in order to remove any spectral 
alterations induced by the instrument.  Details of this system can be found in a previous 
publication by our group [69].  
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5.2.2. Design of the Probe Holder 
A mechanical probe holder was designed and engineered to eliminate the need for a surgeon to 
hold the optical probe throughout a single data acquisition procedure.  The introduction of this 
holder enabled us to identify and, hence, quantify the spectral alterations induced by hand 
movements.  The three critical design criteria of the probe holder were: (1) it had to be able to 
withstand the ethylene oxide gas sterilization procedure; (2) it had to maintain a stable 
investigation location of the probe; and (3) it should maintain constant probe-contact pressure, if 
feasible, against the in vivo brain tissue. The final design of the probe holder is depicted in 
Figure 5.1.  To meet the sterilization criterion, medical grade Stainless Steel 361 was used to 
construct the entire holder. To meet the stability criterion, the probe holder was designed to be 
used in conjunction with the Greenberg self-retaining retractor system. This approach reduced 
the susceptibility of the probe holder to movements of the patient during data acquisition, as the 
Greenberg system [152] was attached directly to the Mayfield head clamp (Integra LifeSciences 
Corp. Cincinnati OH, USA) which was attached to the surgical bed.  The center of the probe 
holder is a stainless-steel tube with an inner diameter slightly larger than the diameter of the 
optical probe.  The optical probe is inserted through the tube and secured using a side screw. To 
enable movement of the optical probe along its primary axis, the center tube was attached to the 
frame of the holder via a two-bar track system (Figure 5.1).  To further facilitate axial 
movements of the optical probe, four springs were used in the track system to suspend the probe. 
The combined spring constant of this suspension system is 250 N/m.  Since the free weight of the 
probe is about 26 g, the displacement of the springs was about 1 mm when the probe was loaded 
to the probe holder. Using the flat punch indentation model of viscoelastic solids derived by 
Harding and Sneddon [153] as well as the shear modulus of the brain reported by Green et al 
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[154], it was found that the addition of the damping springs in the probe holder would also 
reduce the variation in probe contact pressure, resulting from the spontaneous brain movements, 
by about 20% (Table 5.1).  This type of variation in probe contact pressure may be further 
minimized by reducing the overall spring constant.  The trade-off of such an approach, however, 
would be a significant increase in the loading displacement of the springs, and hence the size of 
the probe holder.   
Brain Movement 
(mm) Contact Force (N) 
 k = 0 k = 245 N/m k = 50 N/m 
0.1 0.00635 0.00508 0.001905 
0.5 0.03175 0.0254 0.009525 
1 0.0635 0.0508 0.01905 
Reduction (%) 20% 80% 
 
Table 5.1:   The effects of the damping springs on the probe contact force.  The calculations 
were conducted using the shear modulus of the brain = 5K Pa.  Here k is the total spring 
constant of the probe holder, and k = 0 represents the probe holder without damping 
mechanism.      
 
5.2.3. Data Acquisition and Preprocessing 
In this study, in vivo time-dependent diffuse reflectance spectra Rd(λ,t) were acquired from the in 
vivo brains in the operating room from pediatric patients who were undergoing epilepsy surgery.  
A total of 18 patients were enrolled in the study. From each patient, data was collected from one 
normal site. There was a patient from whom the data was collected from other normal sites as 
well. Hence, the total number of sites was 20. The study was approved by the IRBs at Miami 
Children’s Hospital and Florida International University.  Informed written consent was obtained 
from the parents or guardians of each participant. The patients were divided evenly into two 
groups. In one group, data acquisition was performed with the probe holder (Holder Group). In 
the other group, the probe holder was not used (Hand Group).  
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(a) (b) 
Figure 5.1: (a) Schematic of the mechanical holder for the fiber optic probe. Here h = w = 1 
inch and a = b = 1 inch. (b) The probe holder is attached to a Greenberg retractor system 
during in vivo data acquisition. 
 
 In this trial, spectral data were acquired only from normal cortex, as defined by 
intraoperative electrocorticography and pre-operative imaging. Prior to data acquisition, each 
investigated site was rinsed with saline to remove surface blood, and the surgeon gently placed 
the optical probe in direct contact with the target tissue. In addition, the broadband white light 
source was pre-heated for at least 30 seconds to stabilize its output. Sequentially, 400 Rd(λ,t) 
were acquired from the investigated site at a rate of 30 spectra per second (i.e., 30 ms integration 
time).  Upon completion of spectral acquisition, the white light was turned off and a baseline 
spectrum was acquired to document the influence of ambient light. Every stage of the study 
protocol was carried out under the careful supervision of the surgeons, such that patient care was 
not compromised. 
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 A standard data pre-processing routine was applied to all acquired Rd(λ,t), so as to 
eliminate spectral variations induced by the instrumentation and ambient light [69]. During the 
spectral pre-processing procedure, the range of Rd(λ,t) was reduced to 400-850 nm with a 
wavelength interval of 5 nm. These pre-processing procedures yielded a set of calibrated diffuse 
reflectance spectra Rdcal(λi,t). 
5.2.4. Data Analysis 
Rdcal(λi,t) was analyzed in time, frequency and temporal correlation domains to identify the 
characteristics of spectral alterations induced by hand movements.  Furthermore, the degree of 
improvement in the quality of Rdcal(λi,t) attributable to the probe holder was assessed 
quantitatively.  
 To characterize the temporal alterations induced by hand movements, Rdcal(λi,t) from the 
Holder and the Hand groups were compared empirically by an experienced spectral analyzer 
(WCL). Time variations in Rdcal(λi,t) at a given wavelength were quantified further using its 
percentage standard deviation, which is calculated as 
 
%STD_Rdcal(λi) = STD(Rdcal(λi,t))/MEAN(Rdcal(λi,t)),       (5.1) 
 
where STD is the standard deviation calculation along the time axis, MEAN is the overall 
average calculation along the time axis, and λi = 400 nm to 850 nm at 50 nm intervals.  Finally, 
statistical comparisons were performed of %STD_Rdcal(λi) from the Holder and Hand groups to 
estimate the degree of improvement which can be attributed to the probe holder on the quality of 
acquired data.   
To investigate wavelength-dependency of the temporal spectral alterations in Rdcal(λi,t) induced 
by hand movements, temporal correlation analysis of Rdcal(λi,t) was conducted.  Here, two 
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signals within a single recording set, Rdcal(λi,t) and Rdcal(λref,t), were used to calculate correlation 
coefficients r(λi,λref,t) for a fixed time window (∆t), expressed as  
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+ Δ + Δ
                                          (5.2) 
where COV is the calculated covariance.  In this analysis, λref= 800 nm was used as it is in the 
spectral region where hemoglobin absorption is not prominent, and the window size used was 25 
samples (i.e., ∆t = 750 ms). Again, r(λi,λref,t) from the Holder and Hand groups were empirically 
evaluated to identify wavelength-dependency of spectral alterations in Rdcal(λi,t) induced by hand 
movements. Furthermore, the mean of r(λi,λref,t) over the entire recording duration, denoted as 
MEAN(r(λi, λref, t)), was calculated.  Here, the range of λi was 400 to 850 nm at 50 nm intervals.  
Finally, statistical comparisons were performed of MEAN(r(λi, λref, t)) from the Holder and Hand 
groups to estimate the extent of improvement which can be attributed to the probe holder on the 
quality of acquired data.   
The frequency composition of Rdcal(λi,t) was analyzed to determine the frequency characteristics 
of the spectral alterations induced by hand motions. To eliminate the contribution of the DC 
component to the analysis, the mean intensity over the entire recording period was removed from 
Rdcal(λi,t). That is 
 
 Rdcal_ac(λi) = Rdcal(λi, t) – MEAN(Rdcal(λi,t)                                        (5.3) 
 
Fourier transformation then was applied to Rdcal_ac(λi), which produced a frequency spectrum 
FT_ λi(f).  The absolute value of FT_ λi(f) was computed to yield FTabs_λi(f),which shows the 
magnitudes of the frequency components.  From FTabs_λi(f), locations of the prominent 
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frequency components were identified and their correlations with the physiological 
characteristics of the brain were explored. The power spectral energy of FTabs_λi(f), P(λi),was 
calculated by integrating [FTabs_λi(f)]2 over the entire frequency range, for λi = 400 to 850 nm in 
50 nm intervals. Finally, statistical comparisons were performed with P(λi) from the Holder and 
Hand groups to estimate improvement in the quality of the acquired data caused by the probe 
holder.  
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5.3. Results 
5.3.1 Temporal Variations in Rdcal(λi, t) 
 
(a) (b) 
 
(c) (d) 
 
Figure 5.2: (a) and (b) are the representative Rdcal(λ,t) from the Holder and Hand groups, 
respectively.  (c) and (d) are %STD_Rdcal(λi) calculated using Rdcal(λ,t) from the Holder and 
Hand groups, respectively. Figure legends p1 to p10 are sites from Probe Holder group and h1 
to h10 are sites from Hand Held group. 
 
Temporal variations in Rdcal(λ,t) from the Holder group were insignificant (Figure 5.2a) at all 
wavelengths as shown in Table 5.2.  In contrast, strong variations often were observed in Rdcal(λ,t) 
from the Hand group.  These variations did not possess any predictable nature (e.g., cycling) and 
often occurred at all wavelengths. Results from the quantitative analysis of Rdcal(λ,t) in the time 
domain suggest that time variations in Rdcal(λ,t) from the Holder group, in general, were much 
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less than those from the Hand group (Figures 5.3c and d). Two sample t-tests (for normal data) 
and the Kolmogorov-Smirnov test (for non-normal data) of %STD_Rdcal(λi) further confirmed 
that the decrease in temporal variations in Rdcal(λ,t), resulting from the employment of the probe 
holder, was statistically significant (Table 5.2). In the Hand group, it also is noted that 
%STD_Rdcal(λi) between 400 and 600 nm was stronger than that beyond 600 nm, which suggests 
that Rdcal(λ,t) between 400 and 600 nm was more susceptible to hand movements. 
5.3.2 Temporal Correlation in Rd(λ,t) 
 
 
(a) (b) 
 
(c) (d) 
 
Figure 5.3: (a) and (b) are the representative correlation coefficient maps, r(λi,λref,t), from the 
Holder and Hand groups, respectively.  (c) and (d) are MEAN(r(λi, λref, t)) calculated using 
Rdcal(λ,t) from the Holder and Hand groups, respectively. Figure legends p1 to p10 are sites 
from Probe Holder group and h1 to h10 are sites from Hand Held group. 
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 The correlation coefficient maps, r(λi,λref,t), from  the Holder group were featureless, as 
shown in Figure 5.3a; r(λi,λref,t) fluctuated randomly between -0.5 and 0.5 along the time axis as 
well as the wavelength axis.  In contrast, r(λi,λref,t) from the Hand group often possessed vertical 
bands, where high temporal correlations (| r |> 0.8) were found among the majority of 
wavelength bands. The temporal durations of these vertical bands varied.  Moreover, this vertical 
band may be divided into two segments along the wavelength axis; r(λi,λref,t) above 600 nm was 
greater than 0.8 and r(λi,λref,t) below 600 nm was less than -0.8.  Because of these vertical bands, 
MEAN(r(λi, λref, t)) from the Hand group was generally higher than that from the Holder group. 
This difference, according to a two sample t-test and Kolmogorov-Smirnov test (wherever 
applicable), was statistically significant (Table 5.2). Also, it is noted that the difference in 
MEAN(r(λi, λref, t)) between the two data groups was more pronounced between 400 and 600 nm 
than over the remaining wavelengths.  
5.3.3 Frequency Composition 
Low temporal variations in Rdcal(λ,t) from the Holder group were clearly reflected in their 
corresponding frequency spectra (Figure 5.4a); they were very similar to the frequency spectrum 
of spectrometer noise (no light).  However, FTabs_λi(f) from the Holder group often processed a 
prominent frequency component between 1 and 2 Hz, which was related to the heart rate of the 
studied subject.  As expected, strong temporal variations in Rdcal(λ,t) from the Hand group led to 
more frequency components in their corresponding FTabs_λi(f).  These random frequency 
components, however, were not related to physiological characteristics of the brain (i.e., heart 
rate and breathing rate). Statistically, P(λi) from the Holder group was significantly smaller than 
P(λi) between 400 and 850 nm (Table 5.2). 
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(a) (b) 
 
(c) (d) 
Figure 5.4: (a) and (b) are the representative FTabs_λi(f) from the Holder and Hand groups, 
respectively The green dots on peaks represent the respiration and heartbeat respectively.  (c) 
and (d) are P(λi) calculated using FTabs_λi(f) from the Holder and Hand groups, respectively. 
Figure legends p1 to p10 are sites from Probe Holder group and h1 to h10 are sites from Hand 
Held group. 
 
 Domain 400  
nm 
450 
nm 
500 
nm 
550 
nm 
600 
nm 
650 
nm 
700  
nm 
750  
nm 
800 
nm 
850  
nm 
%STD_Rdcal(λ
i) 
0.003
* 
0.001 0.001 0.001 0.001 0.001 0.000
* 
0.001 0.000 0.001
* 
MEAN(r(λi, λref, t)) 
0.000 0.001
* 
0.000 0.001
* 
0.000 0.000 0.000 0.003
* 
- 0.003
* 
P(λi) 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 
Table 5.2: Results of statistical comparisons (p values) * indicates that a non-parametric test 
(Kolmogorov-Smirnov) was used. 
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5.4. Discussion and Conclusions 
In this study, the effects of hand motions on in vivo optical investigation were evaluated 
qualitatively and quantitatively in time and frequency domains. Hand motion induced 
significantly random variations in acquired diffuse reflectance spectra, and its effects in the short 
wavelength region (i.e., below 600 nm) are more prominent.  These random variations in the 
time domain translate to a significant increase in the power spectral energy in the frequency 
domain. These variations can be strong enough to overwhelm the meaningful signals generated 
by the in vivo physiological characteristics of the investigated tissue (e.g., cardiac cycle).  Even 
more interesting is that the temporal correlation of these spectral alterations exhibit peculiar 
wavelength dependencies: their phases at different wavelength bands may be completely 
opposite under certain circumstances.  The introduction of the probe holder mentioned in this 
paper significantly reduces these temporal variations in the acquired diffuse reflectance spectra, 
while preserving the native signals from in vivo brain.   
 Through the frequency domain and temporal correlation analyses of Rdcal(λ,t), it was 
found that oscillations in the diffuse reflectance spectra, acquired using the probe holder, 
coincide with the rates of the beating heart (1 to 2 Hz) and breathing (0.2 to 0.5 Hz).  This 
indicates that heart beats and breaths alter local hemodynamic characteristics, namely blood 
volume and hemoglobin oxygenation.  These changes, in turn, modify the absorption properties 
of the cortex and, hence, the measured diffused reflectance signals. Spectral alterations induced 
by probe movement can be classified into two categories, based upon the nature of the 
movement.  For lateral probe movements, the spectral alterations originate from spatial 
variations in the optical properties of the cerebral cortex.  This commonly appears as 
synchronized oscillations in diffuse reflectance signals at all wavelengths, and explains the high-
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correlation-coefficient vertical bands in the correlation coefficient maps r(λi,λref,t).  For axial 
probe movement, the spectral alterations are induced primarily by the changes in the regional 
hemodynamics [142].  The changes in hemoglobin oxygenation would lead to wavelength 
dependent increase/decrease in Rdcal(λ,t), and hence the band characteristics in its corresponding 
correlation coefficient maps r(λi,λref,t).   The deformation of the cortex induced by axial probe 
movement, however, should not change its scattering properties because the biological tissue has 
been treated as an incompressible material in studies of tissue mechanical properties.   
 The potential to utilize signal processing techniques to remove motion artifacts from 
recorded signals like Rd(λ,t) have been explored by various groups, including ours. Because of 
the nonlinear and unpredictable nature of the motion artifacts, conventional frequency domain 
filtering would not provide satisfactory results. Consequently, nonlinear filters - such as adaptive 
filtering, wavelet filtering, and independent component analysis - must be used.  Based on our 
experience thus far, none of the existing filtering techniques effectively removes the motion 
artifacts in Rd(λ,t). This is because of the nonlinear effects of motion artifacts on diffuse 
reflectance signals at various wavelengths.  Therefore, we believe that it is better to reduce the 
effects of motion artifacts during the recording stage (using a mechanical holder). 
 Attempts to stabilize the optical probe during in vivo spectral acquisition procedures have 
been made by several groups, where a plain mechanical structure, like a pincer, was used [142, 
155, 156]. Such an approach would eliminate the lateral and axial movements of the optical 
probe induced by the hand, but might not address the irregular probe contact issue induced by the 
spontaneous movements of the in vivo tissue. Based on our experience, in vivo brain movements 
in a surgical environment are significant, because of cardiac cycle and ventilation under 
anesthesia. A plane mechanical holder would yield inconsistent probe contact pressure. Due to 
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the softness of the brain, inconsistent probe contact pressures lead to detrimental tissue 
deformation and, thereby, regional alterations in hemodynamics [142].  The probe holder design 
proposed and tested in this paper took this concern into consideration; the springs in the probe 
holder reduce contact pressure significantly when the probe is placed lightly in contact with the 
brain surface.  In addition, it reduces the amount of force (and, hence, the degree of brain 
deformation) required to move the probe along its primary axis.  In other words, the probe will 
move according to brain surface movement, without drastically changing probe contact pressure. 
This improvement consequently reduces motion artifacts in the optical data.  
 Optical Spectroscopy is being applied increasingly for differentiating various healthy 
body tissues from unhealthy ones. Technological and theoretical advances make it easier to apply 
it to the study of brain tissue. However, if attention is not paid to sources of signal variations, 
researchers risk drawing the wrong conclusions from their data. This is especially true for time-
dependent recordings. In this study the characteristics of the motion artifacts induced by an 
operator’s hand when holding an optical probe, as well as the spontaneous movements of brain 
tissue were quantitatively demonstrated.  Moreover, a new probe holder design that can contain 
motion artifacts to a great extent was introduced; hence, small time-dependent variations in 
diffuse reflectance spectra associated with the intrinsic characteristics of the brain can be 
captured.  
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6. Interictal Characteristics of Epileptic Cortex Measured by Dynamic Diffuse Reflectance   
Spectroscopy 
6.1. Introduction 
Epilepsy surgery is performed for the purpose of freeing children from intractable epilepsy and 
hence adverse effects of recurrent seizures. Detection of epileptic cortex can be achieved via 
studying/observing its abnormal pathophysiological characteristics.  One major feature widely 
used in current practice is the electrophysiological characteristics of the epileptic cortex: 
abnormal electrical discharges during the ictal and interictal periods can be captured and 
localized using EEG and ECoG [157, 158].  The structural abnormality induced by epilepsy may 
be detected by MRI/CT noninvasively and by optical spectroscopy intraoperatively (see Chapter 
3).  Several imaging studies have also shown that epileptic cortex and its surrounding tissue are 
hypometabolic between seizures [159], and become hypermetabolic when seizure occurs [160].  
The alterations in the metabolic state of the epileptic cortex may directly or indirectly affect the 
regional hemodynamics [75, 161]; non-invasive imaging studies [160] and intraoperative 
intrinsic optical signal (IOS) measurements [73] from human subjects show a transient increase 
in regional blood flow, cerebral blood volume, and hemoglobin oxygenation when seizure 
occurs.  Nevertheless, the hemodynamic characteristics of epileptic cortex during the interictal 
period have not yet been investigated.  Here, the dynamic diffuse reflectance spectroscopy 
developed in the previous chapter was used to measure the interictal hemodynamic 
characteristics of pediatric epileptic cortex in vivo.  The results of the study reveals that the 
epileptic cortex possesses unique temporal hemodynamic characteristics, which may be used 
localize and demarcate epileptic cortex intraoperatively.        
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6.2. Materials & Methods 
The details of the instrumentation used in this study, time dependent diffuse reflectance 
spectroscopy system, can be found in the previous chapter and hence not repeated here.  It was 
used to directly acquire diffuse reflectance spectra in the visible wavelength region (i.e., 400 to 
850 nm) as a function of time.  For each patient studied, the optical investigation was performed 
prior to lesion removal and the investigated tissue sites were selected by the surgeons.  At least 
four distinct sites were investigated in a single patient study.  
 Prior to the spectral acquisition, each investigated site was rinsed with saline to remove 
surface blood.  The light source was turned on at least 30 seconds prior to the data acquisition to 
allow its output to stabilize.  With the probe placed gently in direct contact with the cortical 
surface, diffuse reflection spectra Rd(λ,t) were recorded continuously for about 12 seconds at a 
33 Hz rate.  A biopsy was taken from each investigated site, except of those classified as 
normal/functional cortical surface (i.e., outside the resection zone). All biopsies acquired were 
processed using the conventional tissue processing/sectioning routine and then stained using 
hematoxylin and eosin.  The stained tissue sections were then read by a neuropathologist to 
identify those histopathological abnormalities associated with epileptic cortex.  Every stage of 
the study protocol was carried out under the careful supervision of the surgeons such that the 
patient care was not compromised.   
 It has been shown that the cortex outside the zone of resection, defined by intraoperative 
ECoG, do not necessary represent the true normal cortex.  Therefore, pediatric brain tumor 
patients undergoing brain tumor surgery were recruited in this study for the purpose of 
establishing the normal baseline.  The measurement procedure used in the tumor patient study 
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was identical to that described above.  The sites of investigation were selected from the cortex 
outside the zone of resection defined by the pre-surgical imaging studies.             
 Prior to the data analysis, all recorded Rd(λ,t)s were calibrated to remove the artifacts 
induced by instrumentation, which yielded Rdcal(λ,t).  The mechanical probe holder disclosed in 
Chapter 5 was not used in this study because it was not readily available at the beginning of this 
study.  Therefore, Rdcal(λ,t) shown here inevitably contained a certain level of motional artifacts 
originated from the movement of surgeon’s hand.  According to results of several in vitro studies 
regarding hand-motion artifacts (not published), it was found that motion artifacts often exhibit 
statistically high covariance among all optical wavelengths in Rdcal(λ,t). This unique 
characteristic led to the development of a new signal process routine for removal of this type of 
motion artifacts using principal component analysis (PCA) [162]. PCA (or truncated singular 
value decomposition) filtering is based on the subtraction of the eigenvector components 
exhibiting high covariance (i.e., motion artifacts) in the data. The principal components of the 
data covariance were calculated using a standard procedure for singular value decomposition 
(SVD).  Specifically, Rdcal(λ,t) is a m×n rectangular matrix and can be rewritten in the following 
form: 
 Rdcal(λ,t) = u1 s1v1T + u2 s2v2T +… + unsnvnT                                                             (6.1) 
where s1 ≥ s2 ≥ … ≥ sn ≥ 0, U is an m×n orthogonal matrix, S is a n×n diagonal matrix, V is 
another n×n orthogonal matrix.  Since motion artifacts will typically have a highly covariant 
structure, they are generally captured in the first few (strongest) eigenvector components. 
Therefore, they may be removed by subtracting first na of unsnvnT from Rdcal(λ,t).  That is 
  ܴ݀௧௥௨௘ሺߣ, ݐሻ ൌ ܴ݀௖௔௟ሺߣ, ݐሻ െ ∑ ݑ௜ݏ௜ݒ௜௡ೌ௜ୀଵ                              (6.2) 
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 To analyze the time-varying characteristics of Rdtrue(λ,t), correlation coefficient (CC) 
analysis was used.  CC analysis was performed between a reference signal, Rdtrue(λref,t), and a 
comparison signal, Rdtrue(λcomp,t). This calculation yielded γ(λref,λcomp,t) representing the 
temporal correlation between the two diffuse reflectance signals.  Here the reference signal Rdtrue 
(λref,t) was chosen at λref = 800 nm because it is not influenced by hemodynamics (i.e., 
absorption) as much as those in the visible wavelength region and is more sensitive to the 
structural characteristics (i.e., scattering) of the investigated tissue.  The window size for CC 
calculation was 25, which was short enough to capture the transient temporal variations in 
Rdtrue(λcomp, t) and, at the same time, long enough to reduce the effects of the random 
spectrometer noises to the analysis.  The comparisons of γ(λref, λcomp, t) between epileptic cortex 
(defined by ECoG) and normal cortex were carried out using empirical methods.  
 To uncover the underlying mechanisms of the unique features in γ(λref, λcomp, t), a Monte 
Carlo simulation for photon migration (see Chapter 4) was used to stimulate Rd(λ,t) with varying 
blood volume factor (BVF) and oxygen saturation ( 2SatO ).  The alterations in BVF and 2SatO  
directly affected the absorption coefficient µa(λ) [1/cm] of the biological medium.  That is 
 
 
2
2 2( ) [ ( ) (1 ) ( )]
HbO Hb
a a aBVF SatO SatOμ λ μ λ μ λ= × + − ×       (6.3) 
 
where 2 ( )HbOaμ λ  is the absorption coefficient of oxygenated blood [1/cm] and ( )Hbaμ λ is the 
absorption coefficient of deoxygenated blood [1/cm].  The simulated Rd(λ,t)s were analyzed 
using the correlation analysis method described above to produce γsim(λref, λcomp, t), which were 
then compared with those from the in vivo studies to determine the contribution of temporal 
variations in hemodynamics to the variations in γ(λref, λcomp, t). 
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6.3. Results and Discussion 
In this study 19 tumor patients and 26 epilepsy patients were enrolled.  The demographic 
information of these patients can be found in Table 6.1.  A total of 41 sets of Rd(λ,t)s were 
acquired from the tumor patients, which forms the tumor normal group.  A total of 137 sets 
Rd(λ,t)s were obtained from the epilepsy patients: 88 sets were from the cortex within the zone 
of resection (epileptic abnormal group) and 49 sets from the cortex outside the zone of resection 
(epileptic normal group).   
 Figure 6.1 shows a representative result from the CC analysis of Rd(λ,t) from the tumor 
normal group.  Obviously the hand movement of the surgeon introduced significant temporal 
variations in Rd(λ,t) at all wavelengths.  γ(λref = 800 nm, λcomp,t) calculated using the data 
without PCA filtering shows that high temporal correlation was found at all wavelengths during 
the entire recording duration.  This suggests that the spectral artifacts induced by hand motion, in 
this case, are not highly wavelength dependent.  When PCA filtering is applied to the Rd(λ,t), 
significant changes in γ(λref = 800 nm, λcomp,t) are observed.  When the first and second PCs are 
removed from Rd(λ,t), γ(λref = 800 nm, λcomp,t) shows an interesting two-horizontal band 
characteristics: γ(λref = 800 nm, λcomp,t) above λcomp = 600 nm shows a strong positive correlation 
(i.e., γ > 0.8) and γ(λref = 800 nm, λcomp,t) below λcomp = 600 nm shows a strong negative 
correlation (i.e., γ > - 0.8).  Removing more PCs from the raw data does not change the two-band 
characteristic in γ(λref = 800 nm, λcomp,t) until the total number of PCs removed exceeds 50, 
where γ(λref = 800 nm, λcomp,t) becomes completely random and its values vary approximately 
between -0.3 to +0.3.  The above mentioned trend in γ(λref = 800 nm, λcomp,t), resulting from PCA 
filtering, is found to be very common among the data sets from the tumor normal group (Table 
6.2).  However, the number of PCs that have to be removed in order to reveal the two band 
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characteristics in γ(λref = 800 nm, λcomp,t) is site dependent.  This may be explained by the level 
of motion artifacts as well as their spectral and temporal characteristics in the original data.  
 CC analysis reveals many unique wavelength-dependent temporal variations in Rd(λ,t) 
from the epileptic cortex group (ECoG defined).  One of the representative results from the CC 
analysis of Rd(λ,t) from the epileptic cortex group (ECoG defined) is shown in Figure 6.2.  
Again prior to PCA filter, Rd(λ,t) contains a certain level of motion artifacts and its γ(λref = 800 
nm, λcomp,t) shows several high-correlation (> 0.8) vertical bands during the recording period.  
When first three or four PC’s are removed from Rd(λ,t), γ(λref = 800 nm, λcomp,t), it shows an 
interesting four-horizontal band characteristics: a strong positive correlation (i.e., γ > 0.8) is 
found between 600 nm and 800 nm and a strong negative correlation (i.e., γ > - 0.8) between 400 
nm and 450 nm.  Filtered Rd(λ,t)s between 450 nm and 500 nm show positive temporal 
correlation with the reference signal, while Rd(λ,t)s between 500 nm and 600 nm show negative 
temporal correlation with the reference signal.  Removing more than 15 PCs from the raw data 
makes γ(λref = 800 nm, λcomp,t) completely random and its values vary approximately between -
0.3 to +0.3.  Within the data set from epileptic cortex, neither a predictable alteration trend in 
γ(λref = 800 nm, λcomp,t) nor a two-band characteristic observed in the tumor normal  group, 
resulting from PCA filtering, could be observed consistently (Figure 6.3 and Table 6.3).  This 
suggests the two-band characteristic in γ(λref = 800 nm, λcomp,t) may be unique to the normal 
cortex.   
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Date Age & Sex Number of 
Sites 
Date Age & 
Sex 
Number of 
Sites 
Tumor Normal Epilepsy Abnormal 
090507 9F 2 050107 17M 5 
091707 10M 2 050207 3M 3 
092107 5F 2 060407 14M 2 
040108 6F 2 060607 8M 2 
040308 9F 2 061807a 15F 2 
051408 8F 3 062607 15F 3 
061308 5F 2 121207  4 
082808 6F 2 012907 15F 3 
112108 3F 2 021207 8M 1 
120508 14F 3 022707 2M 5 
121208 10F 2 022807 2M 3 
022509 2F 2 031907 12M 2 
022607 13F 2 091907 7M 3 
051507 9F 2 100307 3F 8 
060507 6M 2 100407 15F 2 
061207 12F 2 101107 15F 3 
061807 10M 1 102307 2M 3 
062707 11F 4 102407 10F 3 
080707 1M 2 110507 7F 3 
110607 4M 5 073107 13F 4 
062607 15F 3 081407 18M 2 
062907 9M 2 081507 10M 5 
072407 6M 2 082707 12F 4 
072507 18F 2    
Table 6.1: Demographic information of the epilepsy and tumor patients recruited in the study 
presented.   
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Case Site PC 
Removed 
Variance 
Reduced 
Single 
Band 
Double 
Band 
Multiple 
Band 
No Band 
090507 1 10 98.83%   Y  
 2 4 96.11% Y    
091707 3 1 95.29%  Y   
 4 1 88%  Y   
092107 4 4~10 96~98%   Y  
 5 X X   Y  
040108 1 4~10 96~78%  Y   
 2 3~4 90~93%  Y   
040308 1 1 93.59%  Y   
*No strong 
motion 
artifacts 
2 X X  Y   
051408 1 1,2,3,4 88.89%  Y   
 2 X X Y    
 3 1~10 99.90%  Y   
061308 1 12 98.90%  Y   
 2 2 99.37%  Y   
082808 1 10 99.39% Y    
 2 1~10 99.49%  Y   
112108 
* PCA 
Filtering is 
not very 
helpful 
1 X X  Y   
 3 10 97.76%  Y   
120508 1 4 98.35%  Y   
 2 15 99.79%  Y   
 3 15 99.79%  Y   
121208 1 10 99.32%  Y   
 4 2 94.88%  Y   
022509 1 25 99.85%  Y   
 3 2~10 99.89%  Y   
022607 1 2 93%  Y   
 2 4~10 91~97%  Y   
051507 1 10 96.50%  Y   
 2 10~15 90~94%  Y   
060507 1 15 95%  Y   
 2 15 96%  Y   
061207 1 15 93%  Y   
 2 15 98% Y    
061807 2 X  Y    
062707 1 1,2,3 98%  Y   
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 2 2,3 53~66%  Y   
 3 3,4 89~90%  Y   
 4 4~10 98-99%  Y   
080707 1 10 99.29%  Y   
 2 0 0%  Y   
Table 6.2: PCA filtering and band characteristics for the data sets from the tumor normal group. 
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Date Site PC 
Removed 
Single 
Band 
Double 
Band 
Multiple 
Band 
No 
Band 
Pathology 
050107 
* Band cutoff 
is 500 nm 
4 10~15  Y*   N/A 
 5 25  Y   N/A 
 7 1~2  Y   N/A 
 8 10  Y   Normal 
 9 10  Y   Normal 
050207 2 X   Y  Normal 
 3 1,2  Y   Normal 
 5 25  Y   Normal 
060407 
* PCA 
Filtering is not 
helpful 
4 X    Y Abnormal 
 5 X    Y Abnormal 
060607 5 1~4       Y Abnormal 
   10   Y       
 6 1  Y   Abnormal 
061807a 1 2~10    Y N/A 
 2 2~10     Y   N/A 
   15   Y       
062607 2 0~3 Y       Abnormal 
   4~15       Y   
 3 1~3       Y Normal 
   4~15     Y     
121207 1 0~4     Y   Normal 
   10       Y   
 2 2   Y  Normal 
 5 2~3    Y Abnormal 
 7 4   Y     Abnormal 
   10~15     Y     
012907 1 2~3  Y   Normal 
* With 2 
additional 
weak bands 
2 10~15  Y   Normal 
 4 10~15  Y   Abnormal 
021207 1 0    Y Normal 
022707 1 1  Y   Abnormal 
* Noisy 2 1  Y   Normal 
 3 25  Y   Normal 
 4 4  Y   Abnormal 
 5 1~2   Y     Normal 
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   3     Y     
022807 1 2  Y   Normal 
 2 3  Y   Abnormal 
* 3rd and 4th 
bands are 
weak 
3 10~15   Y  Normal 
031907 3 X    Y Normal 
 4 3~10   Y  Abnormal 
091907 1 2    Y Normal 
 2 1  Y   Normal 
 6 1  Y   Abnormal 
100307 1 1  Y   N/A 
 2 4~10  Y   Abnormal 
*Cutoff at 700 
nm 
3 1~2   Y*     N/A 
   10~25     Y     
 4 0~15       Y N/A 
   25     Y      
 5 10  Y   N/A 
 9 10  Y   Abnormal 
 10 10~15  Y   Abnormal 
 12     Y Abnormal 
100407 1 10~15    Y N/A 
 2 1~15 Y    N/A 
101107 1 X    Y Abnormal 
 2 15  Y   Abnormal 
 3 X    Y Abnormal 
102307 1 10   Y  Normal 
 2 15  Y   Abnormal 
 3 10  Y   Abnormal 
  15   Y   
102407 2 2   Y     Normal 
   4~25     Y     
 3 3   Y     Normal 
   4~25     Y     
 5 10   Y  Abnormal 
110507 1 10  Y   Normal 
 3 1  Y   Normal 
 4 0~4    Y N/A 
110607 1 X    Y Abnormal 
 2 15~25  Y   Abnormal 
 3 10~15   Y  N/A 
 4 1~15 Y    N/A 
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 5 1~15 Y    N/A 
062607 
*Weak 2-band 
2 25  Y*   Normal 
 3 10~15   Y  Abnormal 
* Cutoff at 
650 nm 
6 1  Y*   Abnormal 
062907 1 0~4       Y Abnormal 
   10~15   Y       
 2 0~10 Y       Normal 
   15   Y       
072407 3 1~2  Y   Normal 
 4 X    Y Normal 
072507 1 1~2  Y   Normal 
 2 1   Y     Normal 
   3~15     Y     
073107 1 1~2   Y     Normal 
   3~15     Y     
 2 1~4 Y       Abnormal 
   10~25     Y     
 4 15  Y   N/A 
 5 4  Y   Abnormal 
081407 3 X    Y Normal 
 4 10~15    Y Normal 
081507 2 10~15   Y  Abnormal 
 3 15~25  Y   Normal 
 4 2  Y   Normal 
 6 2~4   Y  Normal 
 7 0   Y  Normal 
082707 
* Cutoff at 
700 nm 
1 0  Y*   N/A 
 2 2   Y     N/A 
   15     Y     
 3 1  Y   N/A 
 5 1  Y   Abnormal 
Table 6.3: Pathology, PCA filtering and band characteristics for the data sets from the epilepsy 
abnormal group. 
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Figure 6.1: CC analysis of Rd(λ,t)  from Site 1 of from Patient 022607 (normal cortex).  
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Figure 6.2: CC analysis of Rd(λ,t) from Site 1 of Patient 121207 (epileptic cortex).   
96 
 
 
 
 
 
 
97 
 
 
 
 
 
 
Figure 6.3: CC analysis of Rd(λ,t) from Site 1 of Patient 091907 (epileptic cortex).  The motion 
artifact is minimal in this set of data; PCA filtering does not change γ(λref = 800 nm, λcomp,t). 
 
 Using the simulated Rd(λ,t) generated by the Monte Carlo simulation for photon 
migration, insights about the underlying physiological mechanisms of the band characteristics in 
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γ(λref = 800 nm, λcomp,t).  When blood volume oscillates and SatO2 remains constant, as shown in 
Figure 6.4, the entire γ(λref = 800 nm, λcomp,t) displays high temporal correlation (γ = 1).  When 
blood volume remains constant and SatO2 oscillates, horizontal band characteristics appear in the 
corresponding γ(λref = 800 nm, λcomp,t).  However, these multi-band features were not observed in 
any of the in vivo data recorded.  Since the increase in blood volume would also lead to an 
increase in the scattering property (i.e., increase in the number of red blood cells), a separate 
simulation was carried out using oscillating BVF and the scattering coefficient and the two-band 
characteristic, as shown in Figure 6.1, was recreated in the corresponding γ(λref = 800 nm, 
λcomp,t).  This attests to the physiological origin of the band characteristics in γ(λref = 800 nm, 
λcomp,t) from the in vivo cortex. 
 The results of this study also show the effectiveness of PCA filtering in removing spectral 
artifacts in Rd(λ,t) induced by hand motion.  When the motion spectral artifacts are synchronized 
temporarily at all wavelengths and much stronger than the actual biological signals, they usually 
occupy the first few principal components and hence can be easily removed using PCA filtering.  
Since the magnitude of the motion artifacts does vary from case to case, it is rather difficult to 
predetermine how many PCs should be removed in order to minimize the effects of motion 
artifacts.  It is suggested here that sufficient PCs should be removed in order to eliminate most of 
the vertical bands while preserving the horizontal bands.  When too many PCs are removed from 
the original signals, γ(λref = 800 nm, λcomp,t) will represent the correlation of the noise and hence 
be completely random.   
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Figure 6.4:  γ(λref = 800 nm, λcomp,t) (bottom) calculated from simulated Rd(λ,t) (top).  Here BVF 
is oscillated between 5% and 3% periodically; and SatO2 is fixed at 3%. 
 
Figure 6.5:  γ(λref = 800 nm, λcomp,t) (bottom) calculated from simulated Rd(λ,t) (top).  Here BVF 
is fixed at 3%; and SatO2 is oscillated between 100% and 60% periodically.  
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6.4. Conclusions 
Time dependent physiological properties of pediatric epileptic cortex were characterized during 
the interictal period using dynamic diffuse reflectance spectroscopy.  The recorded spectral data 
were calibrated and conditioned using the PCA filtering method; their temporal characteristics 
were analyzed using the correlation analysis.  The results of the analysis reveal some unique 
wavelength dependent temporal characteristics of epileptic cortex (i.e., multiple horizontal bands 
in the correlation coefficient map γ(λref = 800 nm, λcomp,t)).  According to the simulation model, 
these characteristics are caused by the temporal alterations in the hemodynamics of cortex.  The 
positive outcome of the study also supports the concept of using time dependent diffuse 
reflectance spectroscopy to detect epileptic cortex intraoperatively.     
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7. Summary and Future Work 
The primary objective of this dissertation is to prove that fluorescence and diffuse reflectance 
spectroscopy can detect interictal pathophysiological characteristics associated with pediatric 
epileptic cortex in an intraoperative environment.  To achieve this goal, three aims were 
designed and studies were carried out, and they were: 
(1) To identify static fluorescence and diffuse reflectance spectral features those differentiate 
between normal and epileptic pediatric cortex defined by pathology. 
(2) To develop a portable fiberoptic spectroscopic system with capability to capture dynamic 
diffuse reflectance spectra from in vivo brain in an intraoperative environment.    
(3) To identify dynamic diffuse reflectance spectral features associated with pediatric epileptic 
cortex defined by ECoG and pathology.   
 The results of the first study show that static diffuse reflectance spectroscopy and its 
combination with static fluorescence spectroscopy can be used to effectively differentiate 
between epileptic cortex (defined by histology) and normal cortex in vivo with a high degree of 
accuracy. The success of this study is attributed to the fact that static hemodynamic 
characteristics of epileptic cortex, namely hemoglobin concentration and oxygenation, are very 
different from those of the normal cortex.  These findings imply the feasibility of using diffuse 
reflectance spectroscopy to localize the histopathological abnormalities associated with pediatric 
epileptic cortex in an intraoperative environment.  The same study also shows that fluorescence 
spectroscopy alone is insufficient in differentiating between epileptic cortex and normal cortex, 
which is attributed to the modulation of cortical optical properties to the fluorescence signals.  
 To maximize the efficiency of optical spectroscopy in detecting and localizing epileptic 
cortex intraoperatively, the static system was upgraded to investigate histopathological 
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abnormalities deep within the epileptic cortex, as well as to detect unique temporal 
pathophysiological characteristics of epileptic cortex.  Detection of deep abnormalities within the 
epileptic cortex required a redesign of the fiberoptic probe.  A simulation model for photon 
migration was developed to evaluate the correlation among source-detector separation (i.e., 
design factor), depth of investigation, and signal strength.  Based on the insights produced by the 
simulation model, it was concluded that the optimal source-detection separation is between 0.6 to 
1 mm and the illumination wavelength should be beyond 600 nm for deep penetration.  To 
capture time dependent characteristics of epileptic cortex, a dynamic diffuse reflectance 
spectroscopy system was designed and constructed.  The system is capable of continuously 
recording diffuse reflectance spectra from the in vivo brain at a high rate (33 Hz) for at least 12 
seconds.  The performance of the system was confirmed through the analysis of the signal to 
noise ratio of the spectrometer and the stability of the excitation light source.  A mechanical 
probe holder was also designed and constructed to maintain the probe contact pressure and 
contact point during the time dependent measurements.  The improvement of the data quality 
introduced by the probe holder was confirmed using an in vivo human study.   
 In the third study, the dynamic diffuse reflectance spectroscopy system was used to 
characterize in vivo pediatric epileptic cortex.  The results of this study shows that some unique 
wavelength dependent temporal characteristics (e.g., multiple horizontal bands in the correlation 
coefficient map γ(λref = 800 nm, λcomp,t)) can be found in the time dependent recordings from 
epileptic cortex defined by ECoG.  According to the simulation model, these characteristics are 
caused by the temporal alterations in the hemodynamics of cortex.  The positive outcome of the 
study also supports the concept of using time dependent diffuse reflectance spectroscopy to 
detect epileptic cortex intraoperatively. 
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 While the research results disclosed in this dissertation support the central hypothesis of 
the research project, there are still many improvements that have to be implemented before 
optical spectroscopy can make a positive impact on future epilepsy surgery.  First of all, the 
analysis of the time dependent recording needs to be enhanced to fully realize the potential of 
dynamic diffuse reflectance spectroscopy in intraoperative localization and demarcation of 
epileptic cortex.  Secondly, the dynamic fluorescence spectroscopy should be developed and 
tested because it will assess the dynamic metabolic characteristics of epileptic cortex, which is 
not achievable using the existing technologies.  Thirdly, the in vivo data acquisition should be 
carried using a non-contact means (i.e., remote sensing) to completely eliminate the artifacts 
induced by inconsistent probe contact pressure as well as brain movement.  Finally, the optical 
recording should be performed simultaneously with the electrical recording (i.e., ECoG) to 
uncover the correlation between the electrical activities of epileptic cortex with their 
physiological characteristics. 
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